Selective deletion of the 5 subunit differentially affects somatic–dendritic versus axonally targeted nicotinic ACh receptors in mouse
1 Division of Biochemistry and Molecular Biology, Centre for Brain Research, Medical University Vienna, Spitalgasse 4, A-1090 Vienna, Austria
2 The Genetic Institute, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, 6 Weizmann Street, Tel Aviv 64239, Israel
3 Center for Neurobiology and Behavior, College of Physicians and Surgeons, Columbia University, 722 West 168th Street, Research Annex Room 807, New York, NY 10032, USA
, 百拇医药
Abstract
We have compared the functional properties of nicotinic acetylcholine receptors (nAChRs) within both somatic and presynaptic domains of superior cervical ganglion (SCG) neurones from wild-type (WT) mice with those expressed by SCG neurones from mice with a targeted deletion of the gene for the 5-subunit. The functional profile of somatic nAChRs was assayed by direct macroscopic current recording and from measurements of nicotinic agonist-induced calcium transients with fura-2 imaging. The profile of nAChRs at presynaptic sites was assayed by measurement of nicotinic agonist-induced transmitter release (as preloaded [3H]noradrenaline) under conditions of action potential blockade. We have examined the responses to the nicotinic agonists acetylcholine, nicotine, cytisine, dimethylphenylpiperazinium iodide (DMPP) and epibatidine. Macroscopic current and calcium imaging assays revealed several differences in the functional profile of somatic nAChRs in WT SCG neurones compared with those from mice with the 5 subunit deleted. Somatic nAChRs in control animals were more potently activated by cytisine as compared to DMPP. In contrast, DMPP was consistently more potent than cytisine in mice lacking the 5 nAChR subunit. Differences in the somatic nAChR rank order of potency were most prominent after a least 1 day in vitro. The magnitude of somatic nAChR responses to nicotinic agonists was not substantially different in control mice compared with those of 5 subunit-deleted animals. Comparison of presynaptic nAChR-mediated responses in WT versus 5 subunit-deleted animals revealed a very different set of changes in the functional profile of prejunctional nAChRs compared with somatic nAChRs. In contrast to somatic nAChRs, the responses of prejunctional receptors were markedly enhanced in 5 knockout animals compared with control. Furthermore, all prejunctional receptor responses were most potently activated by DMPP in both control and in 5 subunit-deleted mice. Hence, the presence or absence of the 5 subunit did not affect the rank order of potency of agonists at preterminal sites but greatly affected the magnitude of presynaptic nAChR-mediated responses. The enhanced efficacy of nicotine at presynaptic receptors was corroborated in an acute atrium preparation from postnatal 5 subunit-deleted mice. These results confirm and significantly extend our previous observation that in the sympathetic nervous system, somatic and prejunctional receptors are different and rely on the presence of the 5 subunit in a distinct manner.
, 百拇医药
Introduction
Neuronal-type nicotinic acetylcholine receptors (nAChRs) play a pivotal role in trans-ganglionic signal transduction of the vegetative; nervous system (Wang et al. 2002b). The properties of these receptors have been studied extensively in the cholinergic (chick) ciliary ganglion (Williams et al. 1998; Conroy et al. 2000; Conroy et al. 2003), and in the chick (Yu & Role, 1998a,b; Devay et al. 1999) and rodent (Covernton et al. 1994; Silvilotti et al. 1997; Kristufek et al. 1999; Cuevas et al. 2000) sympathetic nervous system (for review see Skok, 2002).
, 百拇医药
The principal subunits that make up nAChRs in the vegetative nervous system are 3 and 4 (McGehee & Role, 1995; Skok, 2002). In heterologous expression systems these two subunits are sufficient to form functional receptors (reviewed by McGehee & Role, 1995). However, RT-PCR analysis, measurements of ligand binding, reported effects of -bungarotoxin, and studies of subunit-specific antibodies indicate the presence of 5, 7, 2 and possibly 4 subunits in rodent superior cervical ganglion (SCG) (Skok, 2002). The inclusion of 5, 7 and 2 nAChR subunits into ganglionic 3/4 pairs would be expected to change the functional profile of these receptors (Wang et al. 1996; Ramirez-Latorre et al. 1996; Groot-Kormelink et al. 1998; Gerzanich et al. 1998; Yu & Role, 1998a,b; Nelson & Lindstrom, 1999; Cuevas et al. 2000; Groot-Kormelink et al. 2001; Nelson et al. 2001; Nai et al. 2003).
, 百拇医药
Prior studies of the functional properties of nAChRs expressed by noradrenergic sympathetic or SCG neurones have primarily focused on receptors at somatic sites (Covernton et al. 1994; Mandelzys et al. 1995; Silvilotti et al. 1997; Yu & Role, 1998a,b). However, ganglionic neurones also have presynaptic (or prejunctional) nAChRs that are located on their axonal projections within the various target organs (Brain et al. 2001). Agonist-induced activation of these presynaptic nAChRs may generate antidromic volleys and cause the release of noradrenaline (Krauss et al. 1970).
, 百拇医药
We have previously shown (Kristufek et al. 1999) that prejunctional receptors are more sensitive to the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), whereas somatic receptors in cultured rat SCG neurones are more potently activated by cytisine (Covernton et al. 1994; Kristufek et al. 1999). The distinct pharmacological profiles of somatic versus presynaptic nAChRs indicates fundamental differences in these receptor populations that may be due, at least in part, to differences in the subunit composition of the receptors (McGehee & Role, 1995; Nai et al. 2003). Attempts to dissect the subunit composition of these distinct receptors by comparing the properties of native receptors with receptors of defined composition expressed in heterologous systems have been less than successful in assigning a particular set of subunits that correspond to the functional profiles of rat SCG nAChRs (Covernton et al. 1994; Silvilotti et al. 1997; Lewis et al. 1997).
, 百拇医药
We have chosen a somewhat different tactic to the analysis of native subunit composition, examining the ‘pharmacological fingerprints’ (Covernton et al. 1994; Kristufek et al. 1999) of both somatic and prejunctional nAChRs in neurones from mice with functional deletions of a particular subunit (Champtiaux & Changeux, 2004). This report, as first part in a series of experiments, deals with studies on nicotinic receptors in the SCG from mice with a targeted deletion of the 5 subunit (Wang et al. 2002a,b, 2004; Salas et al. 2003). The general behaviour and gross anatomy of 5 knockout mice are similar to their wild-type littermates (reviewed by Wang et al. 2002b). However, 5 knockout mice are, for example less susceptible to nicotine-induced seizure (Kedmi et al. 2004), have more severe symptoms in experimental colitis (A. Orr-Urtreger, manuscript in preparation), and show an altered cardiac parasympathetic ganglionic transmission (Wang et al. 2002a). For a better understanding of the role of the 5 subunit in ganglionic transmission, the effects of 5 deletion now presented encourage one to take a second look for specific effects of nicotine in such mice.
, 百拇医药
Methods
Animals
Experiments were performed on cell cultures of dispersed SCG neurones or on acute atrial preparations taken from early postnatal mice with 5 subunit deficiency (5 –/–) on C57BL/6J background and their wild-type (5+/+) littermates (Salas et al. 2003).
Cell culture
Superior cervical ganglia were dissected from 4- to 6-day-old mouse pups humanely killed, as required by the Guidelines of the Animal Care Committee, by decapitation. The ganglia were dispersed to single cells, and plated as previously described (Boehm & Huck, 1995). Briefly, ganglia were freed from adhering connective tissue and blood vessels and incubated in a combination of collagenase IA (0.5 mg ml–1, Sigma) and dispase (1.0 mg ml–1, Roche Applied Science) for 20 min at 36.5°C. Subsequently, the ganglia were rinsed three times in Ca2+-free Tyrode solution and trypsinized (0.25% trypsin in Tyrode solution; Worthington) for 15 min at 36.5°C and dispersed by trituration in culture medium. Dispersed neurones were plated either onto 5-mm discs punched out of tissue culture dishes (Nunc) for experiments measuring transmitter release, or onto glass coverslips (Assistent) for patch-clamp recordings and fura-2 spectrofluorometry. Glass coverslips were treated by submersion in concentrated nitric acid for 2 days and thorough rinses thereafter with distilled water. Tissue culture discs and cleaned glass coverslips were coated with poly L-ornithine (100 mg (l H2O)–1; Sigma), followed by 250 μl laminin (Becton Dickinson; dissolved as 0.01 g l–1 in Neurobasal A medium, Gibco-Invitrogen). Approximately, 7500 cells were seeded into glass rings of 6 mm (release experiments) or 8 mm (patch clamp and calcium imaging) in order to confine them to the disc or the centre of the coverslip.
, 百拇医药
The culture medium consisted of Neurobasal A medium, supplemented with the B-27 additive (20 ml l–1; Gibco-Invitrogen), 25000 IU l–1 penicillin, 25 mg l–1 streptomycin (Gibco-Invitrogen), 0.5 mM L-glutamine (Sigma) and 20–50 μg l–1 nerve growth factor (NGF; R & D Systems).
Cultures meant for release experiments were maintained in the presence of 5% fetal bovine serum (Gibco-Invitrogen) and in 5% CO2, whereas the serum-free cultures used for calcium imaging and patch-clamp recordings were kept in 7% CO2.
, 百拇医药
Spectrofluorometry: fura-2 calcium imaging
Measurements of intracellular Ca2+ concentrations were performed at room temperature on an inverted Nikon Diaphot 300 microscope connected to a spectrofluorometrical calcium imaging system (VisiTech, Sunderland, UK). Cells on glass coverslips were ‘loaded’ with dye by incubation in culture medium including 5 μM acetoxymethyl ester form of fura-2 (fura-2 AM Molecular Probes). Preparations were rinsed twice with bathing solution prior to transfer to a recording chamber. The bathing (external) solution used for both calcium imaging and for patch-clamp analysis contained (mM): NaCl 120, KCl 3.0, CaCl2 2.0, MgCl2 2.0, glucose 20 and Hepes 10; adjusted to pH 7.3 with NaOH, and a final osmolarity of 280 mosmol l–1.
, http://www.100md.com
Changes in intracellular Ca2+ concentrations were determined by dual excitation at 340 and 380 nm, and by measuring emission at 510 nm. Measured F340/F380 ratios were transformed into Ca2+ concentration by the eqn (1) of Grynkiewicz (Grynkiewicz et al. 1985):
where Rmin = Sf1/Sf2; Rmax = Sb1/Sb2; Keff = KD x Sf2/Sb2. [Ca2+] is the calculated calcium concentration; Rmin the calibration constant for F340/F380 ratio at zero free calcium; Rmax the calibration constant F340/F380 ratio for 39.8 μM free calcium; R the actually measured F340/F380 ratio; Sf1 the F340 determined by calibration with zero free calcium buffer; Sf2 the F380 determined by calibration with zero free calcium buffer; Sb1 the F340 determined by calibration with 39.8 μM free calcium buffer; Sb2 the F380 determined by calibration with 39.8 μM free calcium buffer; Keff the calibration constant; and KD the dissociation constant for fura-2 (224 nM at room temperature Grynkiewicz et al. 1985). The Keff, Rmin and Rmax calibration constants were determined for a given setting by measuring fura-2 fluorescence intensities in the absence or presence of 39.8 μM free calcium (Calcium Calibration Set, Molecular Probes).
, 百拇医药
Excitation light from a monochromatic fluorescent light source (QuantiCell FSM900, VisiTech) was directed to the sample via an appropriate filter set (Omega). Images were taken with a Nikon Fluor 40x/1.3 Ph4DL oil immersion objective and an intensified CCD camera (Stanford Photonics XR/Mega10 GEN III +). Registration of F340/F380 ratio images was at 1 Hz and controlled by the QuantiCell 2000 software (version 2.0e; VisiTech). We determined the Ca2+ concentrations in single cells off-line by selecting areas of interest from images recorded while applying our test substances. The effects of drugs were assessed by calculating the peak increase in intracellular calcium from baseline values. Nicotinic agonists were dissolved in recording buffer and applied in the presence of 0.5 μM tetrodotoxin (TTX, Latoxan) by a superfusion device (DAD-12, Adams & List) at a rate of one concentration per minute. Application times were adjusted to the occurrence of peak effects (12 s for low concentrations, 6 s for high concentrations of agonists).
, 百拇医药
Simultaneous calcium imaging and perforated-patch voltage-clamp recordings
Neurones loaded with fura-2 AM as described above were also assayed by electrophysiological recordings using perforated patch-clamp techniques (Rae et al. 1991). The recording pipettes had tip resistances of 1.5–3 M when filled with 200 μg ml–1 amphotericin B (Sigma A-4888) in a standard internal solution containing (mM): K2SO4 75, KCl 55, MgCl2 8, Hepes 10, adjusted to pH 7.3 with (KOH). Cells were voltage clamped at –70 mV. For signal processing we used an Axopatch 200A (Axon Instruments) patch-clamp amplifier, a Digidata 1200 (Axon Instruments) A/D converter, and the pCLAMP 8 software (Axon Instruments).
, 百拇医药
[3H]Noradrenaline uptake and superfusion
The techniques for loading cultures with [3H]noradrenaline (NA) and subsequent superfusion for measurement of [3H]NA release were as previously described (Kristufek et al. 1999). Briefly, the cultures were incubated with 0.03 μM [3H]NA in culture medium containing 1 mM ascorbic acid for 60 min at 36.5°C. Culture discs were then transferred to low-volume chambers and superfused at 25°C with buffer containing (mM): NaCl 120, KCl 3, CaCl2 2, MgCl2 2, glucose 20, Hepes 10, fumaric acid 0.5, sodium pyruvate 5.0 and ascorbic acid 0.57; adjusted to pH 7.4 with NaOH. The rate of superfusion was 1 ml min–1, and superfusate was collected in 4-min samples before a 60-min washout period. Residual radioactivity within preparations after the release procedures was determined by extracting cultures at the end of an experiment with 1% sodium dodecyl sulphate (SDS). Radioactivity in extracts and collected fractions was determined by liquid scintillation counting.
, 百拇医药
Stimulation-induced radioactive outflow was achieved by adding nicotinic agonists to the superfusion medium for 15 s. Cultures were challenged with a first stimulus (S1) 12 min after the washout period (i.e. 72 min after initiation of superfusion) and to a maximum of three additional stimuli (S2, S3 and S4) at 20 min intervals. Concentration–response relationships for nicotinic agonists were established by a measuring a maximum of four stimuli with increasing concentrations of the agents in the absence or continuous presence of 0.25 μM TTX.
, 百拇医药
Mouse atria were taken from 6-day-old pups killed by decapitation and collected in ice-cold superfusion buffer containing (mM): NaCl 118, KCl 4.8, CaCl2 2.5, MgSO4 1.2, NaHCO3 25, KH2PO4 1.2, Na2-EDTA 0.03, glucose 11, ascorbic acid 0.57, fumaric acid 0.5 and sodium pyruvate 5.0; and bubbled with 95%O2–5%CO2. Loading of radioactivity was achieved by adding 0.03 μM [3H]NA and 1 mM ascorbic acid to superfusion buffer and incubating atria for 60 min at 36.5°C. One intact atrium was placed thereafter into each chamber and rinsed with superfusion buffer for 60 min before samples were collected at 4 min intervals. In order to block monocemine oxidase A (MAOA) activity and thus reduce the basal outflow of radioactivity, atria were exposed to 0.5 μM clorgyline for 20 min during the initial washout period (Kristufek et al. 2002). Stimulation-induced outflow of [3H]NA was achieved by either electrical field stimulation (120 monophasic pulses delivered at 3 Hz, 0.5 ms, 50 V cm–1, 40 mA), or by adding 100 μM nicotine (in the presence of 0.5 μM TTX) for 15 s to the superfusion buffer. Residual radioactivity was determined by extracting atria at the end of an experiment with 1% SDS and sonication.
, http://www.100md.com
Calculation of basal and stimulation-evoked [3H]NA outflow
Rates of [3H]NA outflow were obtained by dividing the amount of [3H]NA collected during a 4-min period by the total [3H]NA content of cultures at the beginning of the corresponding 4-min collection period (expressed as fractional rate). Basal outflow before the first stimulus (i.e. the basal fractional rate) was termed L1. Stimulation-evoked outflow was calculated as the difference between the total [3H]NA outflow during and after stimulation on the one hand, and the estimated basal outflow on the other hand, assuming that basal release follows a linear decline (Kristufek et al. 1999). The (stimulus-induced) difference was expressed as a percentage of the total radioactivity in the cultures at the beginning of the respective stimulation (S%, see Kristufek et al. 1999).
, http://www.100md.com
Calculation of concentration–response curves and potency ratios
All data are presented as arithmetic means ± S.E.M. The significance of differences was evaluated by means of the unpaired Student's t-test, unless indicated otherwise. Raw data from fura-2 imaging, patch-clamp recordings, and transmitter release experiments were converted into concentration–response curves using self-written script files for SigmaPlot 2000 (SPSS Inc.). Full concentration–response curves for agonists were fitted by unweighted non-linear regression to the logistic equation:
, 百拇医药
where Ex is the response to a certain agonist concentration; x the arithmetic dose; Emax the maximal response; p a slope factor; and EC50 the dose that gives a half-maximal response. Computation utilized either SigmaPlot 2000 (SPSS Inc.) or the ALLFIT program (DeLean et al. 1978). The ALLFIT program calculates parameter estimates for EC50 values, the slope p (which is numerically identical to the Hill coefficient, see DeLean et al. 1978), and Emax, as well as appropriate standard errors and leaves the option to fit curves with or without shared parameters by non-linear regression. The program uses F statistics as the ‘extra sum of squares’ introduced when testing for independent versus shared parameters of two curves.
, 百拇医药
Low-concentration potency ratios were determined according to Covernton et al. (Covernton et al. 1994; Kristufek et al. 1999). Hence, dose–response curves (at the low-concentration end) were fitted simultaneously by non-linear regression with logistic equations that were constrained to be parallel (i.e. with a shared slope parameter, p). The maximum response was fixed to values deduced from full-range concentration–response curves of previous experiments. Adequacy of the fits was judged by eye (e.g. see Figs 2 and 8).
, 百拇医药
Examples are shown from one of the three 5 (+/+) neurones successfully assayed with both calcium imaging and whole cell current recording to assess the effects of agonist at the low end of the concentration–response curve. A, calcium transients, concurrently determined with whole-cell currents, in response to 12-s applications (indicated by bars) of nicotine, cytisine, DMPP or ACh (in the presence of 0.1 μM atropine). Concentrations were 3, 5 and 10 μM (nicotine, cytisine and DMPP, respectively), and 5 and 10 μM (ACh). Sharp deviations in current traces are due to the CCD camera shutter. The experiment was conducted on a 4 DIV preparation. B, dose–response relationship of peak calcium transients constructed from original recordings as shown in A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine (Cyt); dashed lines and open symbols are effects of DMPP (), nicotine (Nic, ) and ACh (). Potency ratios relative to cytisine (1.0) were 0.75 (DMPP), 0.51 (nicotine) and 0.39 (ACh). C, dose–response relationship of peak currents constructed from original recordings as shown in panel A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine; dashed lines and open symbols are effects of DMPP (), nicotine () and ACh (). Potency ratios relative to cytisine (1.0) were 0.81 (DMPP), 0.63 (nicotine) and 0.48 (ACh).
, http://www.100md.com
A1, transmitter release was evaluated in preparations of SCG obtained from 5 (+/+) mice at 5 DIV that were preloaded with [3H]NA as described in Methods. Responses to DMPP () and cytisine () in the presence of 0.25 μM TTX are shown. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Triangles and continuous line show the concentration–response curve for cytisine; dashed line and squares are effects of DMPP. In this assay, the potency of DMPP exceeded cytisine by a factor of 2.33 ± 0.03 (n = 3 individual cultures). This experiment, done in triplicate with 5 DIV cultures, yielded a mean potency ratio of 2.12 ± 0.16 (n = 9 cultures; see B1). A2, same experimental protocol as shown in A1, except that transmitter release was determined in 5 DIV cultures obtained from 5 (–/–) mice. The potency of DMPP exceeded cytisine by a factor of 2.39 ± 0.12 (n = 3 individual cultures). This experiment, done in triplicate with 5 DIV cultures, yielded a mean potency ratio of 2.00 ± 0.11 (n = 9 cultures; see B2). B1, time course of potency ratios determined in preparations of SCG obtained from 5 (+/+) mice after 2, 5 and 8 DIV. For each time point, the effects of DMPP and cytisine were determined in at least three release experiments similar to the one shown in A1. B2, time course of potency ratios determined in preparations of SCG obtained from 5 (–/–) mice after 2, 5 and 8 DIV. For each time point, the effects of DMPP and cytisine were determined in at least three release experiments similar to the one shown in A2.
, 百拇医药
Materials
Materials and reagents were obtained as noted and from the following sources: (–)-[ring-2,5,6 3H]noradrenaline (56.9 Ci mmol–1, NEN); acetylcholine chloride (ACh), 1,1,-dimethyl-4-phenylpiperazinium iodide (DMPP) cytisine, epibatidine and clorgyline hydrochloride from Sigma; and all other chemicals were from Merck (analytical grade).
Results
In the current series of experiments we established pharmacological fingerprints of somatic and prejunctional receptors in cultured SCG neurones by comparing the responses to five established nicotinic agonists: nicotine, cytisine, DMPP, ACh and epibatidine. Due to the relatively high calcium permeability of neuronal-type nAChRs, as compared with their muscle nAChR cousins (reviewed by McGehee & Role, 1995), the properties of receptors at somatic sites could also be assessed by spectrofluorometry using the Ca2+-sensitive dye, fura-2, in addition to patch-clamp recording. As in our previous study (Kristufek et al. 1999), functions of prejunctional receptors were monitored by measuring the outflow of preloaded [3H]NA as a result of calcium influx at sites of transmitter release. Generation of action potentials, and ensuing calcium entry through voltage-gated calcium channels, was prevented by adding TTX to the buffer solutions. We have shown previously that under these conditions, nicotinic agonists are unable to depolarize SCG varicosities sufficient for an activation of high voltage-activated calcium channels (Kristufek et al. 1999).
, 百拇医药
Somatic nAChRs: assessment of function by full concentration–response curves of nicotinic agonists and differences in rank order of potency between 5 (+/+) and 5 (–/–) mice
An assessment of potencies of nicotinic agonists by calcium imaging using fura-2, and deduced from full concentration–response curves in 5 (+/+) mouse SCG neurones after 4–5 days in vitro (DIV) (4/5 DIV) produced results very similar to patch-clamp observations previously made in the rat SCG (Covernton et al. 1994; Kristufek et al. 1999). Hence, out of the four classical agonists, cytisine was most potent to activate somatic receptors, followed by DMPP, nicotine and ACh (in the presence of 0.1 μM atropine; Fig. 1; Table 1). Potency ratios calculated from EC50 values (Table 1) relative to the standard cytisine (1.0) were 0.80 (DMPP), 0.64 (nicotine) and 0.26 (ACh). These values are strikingly close to those obtained in rat (DMPP, 0.62; nicotine, 0.60; Ach, 0.34; all relative to cytisine Kristufek et al. 1999). In all assays presented in our present study, the potency of epibatidine exceeded the most potent concurrent nicotinic agonist by at least three orders of magnitude (Figs 1 and 7, and Table 1 and 2).
, 百拇医药
A–E, calcium transients in the soma region were recorded by fura-2 calcium imaging in response to DMPP (A), cytisine (B), nicotine (C), ACh (in the presence of 0.1 μM atropine, D) and epibatidine (E). Recordings were done in the presence of 0.5 μM TTX. Full concentration–response curves for each of the agonists were determined in at least 20 neuronal somata of two to three different preparations of control or of 5 (–/–) neurones (4–5 DIV). Values of individual cells were normalized with respect to the concentrations yielding maximum response (DMPP and nicotine, 67 μM; cytisine and Ach, 200 μM; epibatidine, 67 nM), and then fitted for determination of EC50 values using eqn (2). Results from 5 (+/+) animals are indicated by filled symbols and continuous lines, those from 5 (–/–) by open symbols and dashed lines. Fitted parameters are summarized in Table 1. There were only minor differences in EC50 values between genotypes with the exception of cytisine. Cytisine was more potent in 5 (+/+) as compared to 5 (–/–) mice (EC50: 5 (+/+), 9.27 ± 0.18 μM; 5 (–/–), 14.95 ± 0.47 μM; P < 0.01). F, maximum calcium signal for each agonist at somatic nAChRs obtained by fitting the dose–response to eqn (2) without prior normalization. Open columns are results from 5 (+/+) mice, hatched columns are the surplus of responses as seen in 5 (–/–) animals. All agonists show a tendency towards higher efficacy in the 5 (–/–) responses, although the difference is only significant for DMPP (344 ± 11 nMversus 443 ± 17 nM; n = 20 and 24 for 5 (+/+) and 5 (–/–) mice, respectively; P < 0.01), epibatidine (499 ± 24 nMversus 599 ± 28 nM; n = 20 for both 5 (+/+) and 5 (–/–); P < 0.05) and cytisine (370 ± 17 nMversus 438 ± 23 nM; n = 26 and 30 for 5 (+/+) and 5 (–/–); P < 0.05). Maximal effects of ACh in 5 (+/+) animals (530 ± 29 nM; n = 20) were significantly larger than effects of DMPP (P < 0.01), cytisine (P < 0.01), and nicotine (P < 0.05). In 5 (–/–) animals, the maximal effects of ACh (551 ± 27 nM; n = 22) significantly exceeded those of DMPP and cytisine (P < 0.01).
, 百拇医药
A–E, transmitter release overflow was evaluated in preparations at 4–6 DIV that were preloaded with [3H]NA as described in Methods. Responses in the presence of 0.25 μM TTX to DMPP (A), cytisine (B), nicotine (C), ACh (in the presence of 0.1 μM atropine, D) and epibatidine (E) are shown. Data points show the number of counts min–1 of [3H]NA normalized with respect to the maximum effect for each agonist in a particular experiment (DMPP, 66–100 μM; nicotine, 60–120 μM; cytisine, 75–166 μM; Ach, 150–600 μM; epibatidine, 66–100 nM) and are the averaged values from three individual cultures. Note that beyond these maximum concentrations, the effect of agonists decline again. Curves show the results of fitting eqn (2) to data points with the constraint that the maximum response was set to 1.0. Data points of supramaximal agonist concentrations were excluded from the fits. Fit parameters for EC50 values and the slope factors are shown in Table 2. The symbols used to depict results for 5 (+/+) and 5 (–/–) animals, respectively, are indicated in each panel. F, the maximal NA release was calculated by averaging all maximal effects an agonist had in individual cultures of either the 5 (+/+) or the 5 (–/–) genotype. Data are means ± S.E.M.; n = 9 (DMPP at 5 (+/+)) to 27 (cytisine and ACh at 5 (–/–)) individual cultures. Open columns are results from 5 (+/+) mice, hatched columns are the surplus of responses as seen in 5 (–/–) animals. Note the striking difference of the maximal release which is independent of the type of agonist (P < 0.01). The overall maximal NA outflow (pooled data from all five agonists) was 2.67-fold larger in 5 (–/–) than in 5 (+/+) animals (5 (+/+), 6.82 ± 0.49%, n = 65; 5 (–/–), 18.23 ± 0.42%, n = 112; P < 0.01). Maximal effects of ACh in 5 (+/+) animals (7.63 ± 1.28 %; n = 15 individual cultures) did not significantly differ from the maximal effects of the other agonists (P > 0.05). Maximal effects of ACh in 5 (–/–) animals (18.39 ± 1.01 %; n = 27 individual cultures) did not significantly differ from the maximal effects of the other agonists (P > 0.05).
, 百拇医药
With one notable exception, cytisine, the EC50 values for the activation of somatic receptors were not substantially different in 5 (+/+) and 5 (–/–) mice (Fig. 1; Table 1). Cytisine was about 1.6 times less potent in the 5 (–/–) mice compared with 5 (+/+) controls (Fig. 1; Tables 1, P < 0.01). This shift of potency was sufficiently large to change the rank order of agonist potency in the 5 (–/–) animals to DMPP (1.50), followed by cytisine (1.0), nicotine (1.00) and ACh (0.42).
, 百拇医药
In addition to the significant effects on rank order of agonist potency, there was a trend towards increased efficacy of a subset of the nicotinic agonists, as assessed from the magnitude of the somatic responses in 5 (–/–) versus 5 (+/+)-derived neurones (Fig. 1F). Thus, the maximum increases in calcium measured in 5 (–/–) animals were significantly larger in response to cytisine (P < 0.05), DMPP (P < 0.01) and epibatidine (P < 0.05) but did not differ significantly for nicotine and ACh (Fig. 1F). The trend towards a higher maximum responses was also apparent in analyses of data pooled for all agonists (Fig. 1F, overall). Hence, in 5 (–/–) mice, the maximum increase of calcium in response to the agonists exceeded the effects in 5 (+/+) mice by a factor of 1.14 (P < 0.01, n = 113 and 123 for 5 (+/+) and 5 (–/–) mice, respectively).
, 百拇医药
Somatic nAChRs: assessment of function by low concentration potency ratios confirms results of full concentration–response curves
Estimates of EC50 values when deduced from full concentration–response curves may be misleading (Covernton et al. 1994; Kristufek et al. 1999). Therefore, we used an additional approach to compare the potencies of our four standard agonists at concentrations not exceeding EC50 values (‘low-concentration potency ratios’, see Covernton et al. 1994). This approach minimizes the contribution of receptor desensitization seen at high concentration of agonists and eliminates ‘between neurone’ variance as comparative measurements of potency ratios can be done on the same cells (Figs 2 and 3). Potency ratios determined from individual neurones could then be pooled for calculation of the statistics (Fig. 4).
, 百拇医药
Examples are shown from one of the three 5 (–/–) neurones successfully assayed with both calcium imaging and whole cell current recording to assess the effects of agonist at the low end of the concentration–response curve. A, calcium transients, concurrently determined with whole-cell currents, in response to 12-s applications (indicated by bars) of nicotine, cytisine, DMPP or ACh (in the presence of 0.1 μM atropine). Concentrations were 3, 5 and 10 μM (nicotine, cytisine and DMPP, respectively), and 5 and 10 μM (ACh). Sharp deviations in current traces are due to the CCD camera shutter. The experiment was conducted on a 4 DIV preparation. B, dose–response relationship of peak calcium transients constructed from original recordings as shown in A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine (Cyt); dashed lines and open symbols are effects of DMPP (), nicotine (Nic, ) and ACh (). Potency ratios relative to cytisine (1.0) were 1.21 (DMPP), 0.74 (nicotine) and 0.37 (ACh). C, dose–response relationship of peak currents constructed from original recordings as shown in A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine; dashed lines and open symbols are effects of DMPP (), nicotine () and ACh (). Potency ratios relative to cytisine (1.0) were 1.49 (DMPP), 0.88 (nicotine) and 0.49 (ACh).
, http://www.100md.com
A, low-dose potency ratios were determined in individual cells from 5 (+/+) mice at the indicated age of cultures and as shown in Fig. 2 for a cell after 4 DIV. Data points are mean potency ratios ± S.E.M. (relative to the standard, cytisine) of 6 (1 DIV), 12 (2 DIV), 21 (4 DIV), 7 (6 DIV), 2 (9 DIV) and 6 (12 DIV) neurones. Filled inverted triangles and continuous line show the potency ratio for cytisine, set to unity; dashed lines and open symbols are the ratios of DMPP (), nicotine () and ACh (in the presence of 0.1 μM atropine, ). Note the significant change of potency ratios, particularly for DMPP, between 1 and 6 DIV (P < 0.01). At 1 DIV, the DMPP to cytisine ratio was 0.30 ± 0.02 (n = 6; significantly different from 1: P < 0.01), from where it increased up to 0.95 ± 0.01 (n = 7) after 6 DIV. B, results obtained from 5 (–/–) mice by the protocol described in A; symbols identical to A. Data points are mean potency ratios ± S.E.M. (relative to the standard, cytisine) of 6 (1 DIV), 16 (4 DIV), 8 (6 DIV), 14 (7 DIV) and 8 (12 DIV) neurones. Note that regardless of the age of cultures, DMPP was consistently more potent than cytisine. At 1 DIV, the DMPP to cytisine ratio was 1.39 ± 0.01 (n = 6; significantly different from 1: P < 0.01). At 7 DIV, the DMPP to cytisine ratio was 1.37 ± 0.02 (n = 14).
, 百拇医药
Potency ratios determined at lower agonist doses confirmed our findings on the differences in rank order potency and potency ratios of neurones from 5 (+/+) versus 5 (–/–) mice, as deduced from the EC50 values. Hence, in SCG neurones of 5 (+/+) mice, cytisine was the most potent agonist, followed by DMPP and nicotine, and then ACh (1, 0.67 ± 0.02, 0.68 ± 0.03 and 0.51 ± 0.02, respectively; means ± S.E.M., n = 21 from four different preparations; see Fig. 4A, data points at 4 DIV). In contrast, examination of SCG neurones from 5 (–/–) mice revealed the distinct rank order potency of DMPP > cytisine > nicotine > > ACh. Thus direct assessment of low-concentration potency ratios (cytisine, 1; DMPP, 1.34 ± 0.02; nicotine, 0.90 ± 0.01; Ach, 0.30 ± 0.01; means ± S.E.M., n = 16 out of three different preparations; see Fig. 4B, data points at 4 DIV) confirms the results obtained from full dose–response curves.
, 百拇医药
Simultaneous fura-2 calcium imaging and patch-clamp recordings in the same cell further confirmed the differences of somatic nAChRs agonist potency ratios between 5 (+/+) and 5 (–/–) mice. Both techniques yielded identical potency ratios in within genotype comparisons of either 5 (+/+) or 5 (–/–) mice (compare Figs 2 and 3). It is notable that the time course of calcium transients was much slower than the evoked currents recorded in response to application of agonists. In addition we noted a trend towards higher magnitude changes in DMPP-evoked Ca2+ signalling in neurones from 5 subunit-deleted mice (compare Figs 2 and 3).
, 百拇医药
Potency ratios are affected by the age of cultures in 5 (+/+) mice, but not in 5 (–/–) mice
All observations presented so far were made on mouse SCG neurones maintained in culture for 4–5 days. However, the subunit composition of nAChRs changes with the age of cultures (De Koninck & Cooper, 1995). We therefore wanted to know whether these changes were paralleled by an adjustment of potency ratios. It is striking that cytisine has an exceedingly high potency compared to the other agonists when tested after 1 DIV in SCG neurones from 5 (+/+) mice (potency ratio of DMPP compared to cytisine, 0.30 ± 0.02, means ± S.E.M.; n = 6 of two preparations, Fig. 4A). By 4 DIV, the ratio declined to 0.67 ± 0.02 (n = 21 of four preparations, see above), and after 6 DIV, DMPP and cytisine were almost equipotent in neurones from 5 (+/+) mice (cytisine, 1; DMPP, 0.95 ± 0.01, n = 7 of two preparations; difference to 1 DIV significant at P < 0.01). The changes in the potency of nicotine and ACh initially followed the time course of DMPP, but then declined relative to DMPP after 9 and 12 DIV (Fig. 4A).
, http://www.100md.com
In contrast to the developmental changes in somatic responses in 5 (+/+) animals, somatic nAChRs of 5 (–/–) mice remained about constant throughout the incubation period. DMPP was more potent than cytisine at all points examined (potency ratio after 1 DIV, 1.39 ± 0.01; n = 6 of two preparations, Fig. 4B). Hence, the 5 genotypes were most distinct at 1 DIV, when potency ratios between DMPP and cytisine differed by the quotient 1.39/0.30 (i.e. 4.63). Overall, these data are consistent with changes in the nAChR composition with in vitro development of 5 (+/+) neurones that does not occur when the 5 subunit is absent.
, 百拇医药
TTX-sensitive versus TTX-insensitive transmitter release
Experiments delineated above assess the pharmacological fingerprints of somatic nAChRs in SCG neurones from both 5 (+/+) and 5 (–/–) mice. Our next task was to apply a similar analysis to determine the functional profile of the presynaptic receptor pools. As detailed in a previous study (Kristufek et al. 1999), the function of prejunctional receptors was monitored indirectly by measuring the outflow of preloaded [3H]NA in response to nicotinic agonists. The component of transmitter outflow that remains upon stimulation with nicotine in the presence of TTX (‘TTX-insensitive transmitter release’) thus reflects the function of presynaptic receptors (Kristufek et al. 1999). Subtraction of this component from overall release (i.e. in the absence of TTX) reveals the ‘TTX-sensitive component’.
, http://www.100md.com
We first examined whether SCG neurones from mice, like those from rat, have both the TTX-sensitive as well as the TTX-insensitive component. Results from these experiments for both 5 (+/+) and 5 (–/–) animals are shown in Fig. 5. Curve fits of data points by eqn (2) yielded identical EC50 values for the TTX-insensitive component of nicotine-induced transmitter outflow in 5 (+/+) and 5 (–/–) mice (5 (+/+), 37.46 μM; 5 (–/–), 37.04 μM, Fig. 5). Note, however, that the maximum of the TTX-insensitive component was strikingly different between 5 (–/–) and 5 (+/+) mice. As shown in more detail below (Fig. 7), TTX-insensitive transmitter release was significantly enhanced in 5 (–/–) mice not only in response to nicotine, but also by the other agonists tested.
, 百拇医药
A1, exploring full concentration–response curves in 5 (+/+) mice. Nicotine-induced transmitter release from 5 DIV SCG cultures under control conditions (overall release, ) and in the presence of 0.25 μM TTX (TTX-insensitive release, ). Data are means ± S.E.M., n = 3 individual culture discs. Data points indicated by circles (TTX-sensitive release) were obtained by subtracting mean values of nicotine-induced release in the presence of TTX () from overall release (). A2, curve fits of TTX-sensitive () and TTX-insensitive () nicotine-induced transmitter release by applying eqn (2) yielded the following parameters: EC50 TTX-sensitive, 15.82 ± 2.52 μM; EC50 TTX-insensitive, 37.46 ± 0.98 μM; maximal effect TTX-sensitive, 2.81 ± 0.22%; maximal effect TTX-insensitive, 3.47 ± 0.06%; slope factor p for TTX-sensitive, 2.03 ± 0.48; slope factor p for TTX-insensitive, 4.82 ± 0.42. Data points for the curve fits were taken from A1. A3, exploring the low concentration end of the dose–response curve. Nicotine-induced transmitter release from 2 DIV SCG cultures of 5 (+/+) mice under control conditions (overall release, ) and in the presence of 0.25 μM TTX (TTX-insensitive release, ). Means ± S.E.M., n = 3 release experiments. Each data point was calculated from three triplets of individual culture discs. The data points indicated by circles (TTX-sensitive release) were obtained by subtracting mean values of nicotine-induced release in the presence of TTX () from overall release (). Note that TTX-sensitive release reached a near maximal value of 5.52 ± 0.31% (n = 3 cultures in triplicate) at 30 μM nicotine. B1 and B2, same experimental protocols as shown in A1 and A2, except that transmitter release was determined in 4 DIV cultures obtained from 5 (–/–) mice. Fitting curves by eqn (2) to the data points shown in B1 yielded the following parameters: EC50 TTX-sensitive, 11.71 ± 2.13 μM; EC50 TTX-insensitive, 37.04 ± 0.56 μM; maximal effect TTX-sensitive, 5.23 ± 0.63%; maximal effect TTX-insensitive, 15.58 ± 0.18%; slope factor p for TTX-sensitive, 2.59 ± 1.01; slope factor p for TTX-insensitive, 3.58 ± 0.15. Note that in comparison with 5 (+/+) mice, the two preparations differ grossly in their maximal values of the TTX-insensitive component. B3, same experimental protocols as shown in A3, except that transmitter release was determined in 2 DIV cultures obtained from 5 (–/–) mice. Note that TTX-sensitive release reached a maximum of 5.79 ± 0.19% (n = 3 cultures in triplicate) in response to only 10 μM nicotine (versus 30 μM in 5 (+/+) mice).
, http://www.100md.com
TTX-sensitive release was induced with an EC50 of 15.82 μM in 5 (+/+) and an EC50 of 11.71 μM in 5 (–/–) mice (Fig. 5A2 and B2) and thus appeared to be more potently activated in animals lacking the 5 subunit. A plausible explanation for the higher potency of nicotine in inducing TTX-sensitive release in 5 (–/–) mice might be a higher efficacy of the agonists on nAChRs assembled without the contribution of 5 subunits. If this were the case, and assuming that neither the properties or distribution of voltage-gated sodium channels are affected by the 5 subunit genotype, a lower concentration of nicotine might suffice to depolarize neurones to the threshold level for the activation of sodium channels. We tested this hypothesis by exploring transmitter release upon exposure of cultures to low concentrations of nicotine in the presence and absence of TTX (Fig. 5A3 and B3). Our experiments revealed that the TTX-sensitive component reached about the same maximum in both 5 (+/+) and 5 (–/–) mice. However, maximal effects were obtained with 10 μM nicotine in 5 (–/–) animals, whereas it took about 30 μM of nicotine in 5 (+/+) mice (Fig. 5A3 and B3).
, 百拇医药
These observations are compatible with the idea that nAChRs assembled in 5 (–/–) mice are activated more efficaciously by nicotine than those in 5 (+/+) controls. Note that release measured in all cases is entirely dependent on the presence of calcium in the superfusion buffer even in 5 (–/–) animals, where the TTX-insensitive component of nicotine-induced transmitter release is markedly enhanced relative to control (Fig. 6). On average, 100 μM nicotine causes a 22.8 ± 4.1% (n = 24) depletion of radioactivity in cultures after 2 DIV (see Fig. 9).
, 百拇医药
Basal transmitter release and the release induced by 100 μM nicotine (15 s, indicated by arrows) in the presence of 0.25 μM TTX. Control buffer containing 2 mM Ca2+ (cultures 3 DIV, ); superfusion buffer with and without (indicated by horizontal bar) 2 mM Ca2+ (cultures 2 DIV, ). Data points are means ± S.E.M., n = 3.
A, somatic receptors: SCG cultures from either 5 (+/+) or 5 (–/–) mice were maintained for 1 DIV (open columns), 4/5 DIV (filled columns), or 7 DIV (hatched columns). Maximal effects of nicotine were determined by fitting eqn (2) to calcium transients in response to a full range of nicotine concentrations as shown in Fig. 1F. Note that nicotine exerted highest effects at 4/5 DIV both in 5 (+/+) and 5 (–/–) mice. In 5 (+/+) mice, values at 4/5 DIV were significantly larger than at 1 DIV (P < 0.05) or 7 DIV (P < 0.01). In 5 (–/–) mice, values at 4/5 DIV significantly exceed those at 7 DIV (P < 0.05). Maximal effects of nicotine were significantly larger in 5 (–/–) than in 5 (+/+) mice at 1 DIV and 7 DIV (P < 0.01). Data are means ± S.E.M., n = 9–27 individual cells. B, prejunctional receptors: transmitter release in response to 100 μM nicotine in the presence of 0.25 μM TTX. SCG cultures from either 5 (+/+) or 5 (–/–) mice were maintained for 2 DIV (open columns), 5 DIV (filled columns), or 8 DIV (hatched columns). Data are means ± S.E.M., n = 24 individual cultures (at 2 DIV), 12 (at 5 DIV) and 9 (at 8 DIV). Note that in the presence of TTX, 100 μM nicotine will cause maximal transmitter release (see Figs 5 and 7), and that at all ages, cultures obtained from 5 (–/–) mice showed significantly more agonist-induced NA release than 5 (+/+) animals. NA release in response to nicotine significantly declined between 5 DIV and 8 DIV both in 5 (+/+) and 5 (–/–) animals (P < 0.01), and between 2 DIV and 5 DIV in cultures taken from 5 (–/–) mice (P < 0.01).
, 百拇医药
Prejunctional nAChRs: assessment of function by full concentration–response curves of nicotinic agonists in 5 (+/+) and 5 (–/–) mice
Having assessed the basic properties of TTX-sensitive and TTX-insensitive transmitter release in both 5 (+/+) and 5 (–/–) mice we next examined the pharmacological profile of the prejunctional nAChRs in the 5 (+/+) and 5 (–/–) animals in more detail. EC50 values deduced from full concentration–response curves indicate a lower potency of DMPP and ACh, but not of nicotine or cytisine, in 5 (+/+) mice (Fig. 7; Table 2) as compared to the rat SCG (Kristufek et al. 1999). Potency ratios calculated from EC50 values relative to cytisine (1.0) in 5 (+/+) mice were: DMPP, 1.61; nicotine, 1.64; Ach, 0.28. In Sprague-Dawley rats, ratios were: DMPP, 2.17; nicotine, 1.41; and Ach, 0.43 (data in rats taken from Kristufek et al. 1999).
, 百拇医药
Deletion of the 5 subunit as evaluated from the transmitter release assay shifted the EC50 values of all agonists except of cytisine towards a higher potency (Fig. 7; Table 2). Nevertheless, potency ratios in 5 (+/+) controls closely resembled the values of 5 (–/–) animals (cytisine, 1; DMPP, 1.84; nicotine, 1.59; Ach, 0.47).
However, the most conspicuous effect of the deletion of the 5 subunit was the impact it had on the efficacy of nicotinic agonists: all agonists tested stimulated a higher level of release at significantly lower doses in 5 (–/–) compared with 5 (+/+) animals (Fig. 7F). Transmitter release upon activation of prejunctional receptors was enhanced by nearly 3-fold (Fig. 7F).
, 百拇医药
Prejunctional nAChRs: assessment of function by low-concentration potency ratios confirms results from full concentration–response curves
Analogous to our assessment of the function of somatic nAChRs mentioned above we sought confirmation of the potency ratios calculated from EC50 values by applying the two most discriminating agonists, cytisine and DMPP, at low concentrations (Fig. 8). After 5 DIV, DMPP was 2.12 ± 0.16 (n = 3 release experiments) and 2.00 ± 0.11 (n = 3 release experiments) times more potent than cytisine in the 5 (+/+) and 5 (–/–) animals, respectively (Fig. 8). In cultures examined between 2 DIV and 8 DIV, DMPP was consistently more potent than cytisine in both 5 (+/+) and 5 (–/–) animals (Fig. 8B1 and B2).
, 百拇医药
Age-dependent properties of SCG cultures: impact of the time in vitro on agonist efficacies
As mentioned above, the age of cultures had a significant impact on the relative potency of nicotinic agonists at somatic receptors in 5 (+/+) mice (Fig. 4). However, the age of cultures also affected the overall efficacy of nicotine. Hence, in both 5 (+/+) and 5 (–/–) animals, the increase of intracellular calcium obtained by nicotine reached a maximum at 4 DIV and declined markedly after 7 DIV (Fig. 9A).
, 百拇医药
The time course of the changes in efficacy of nicotine at prejunctional receptors was determined by measuring transmitter outflow in response to a standard concentration of 100 μM nicotine (in the presence of TTX) at several different DIV and for both the 5 (+/+) and 5 (–/–) genotypes (2, 5, and 8 DIV; Fig. 9B). As noted for somatic receptors, the efficacy of nicotine significantly declined between 5 and 8 DIV in both genotypes, and between 2 and 5 DIV in 5 (–/–) mice. The waning of the effect of nicotine between 5 and 8 DIV was not due to a general loss in the release capacity of cultures, as transmitter outflow in response to electrical field stimulation did not differ significantly either in 5 (+/+) or in 5 (–/–) mice between 5 and 8 DIV (P > 0.05; data not shown).
, http://www.100md.com
Prejunctional nAChRs: assessment of the efficacy of nicotine in the atrium preparation of 5 (+/+) and 5 (–/–) mice
We corroborated the increased efficacy of prejunctional nicotinic receptors in an acute atrium preparation taken from 6-day-old animals (Fig. 10). Transmitter release induced by a concentration of nicotine that we know caused maximal effect under conditions of action potential blockade (Figs 5 and 7) was significantly larger in 5 (–/–) compared to 5 (+/+) mice (Fig. 10). In contrast, transmitter release in response to electrical field stimulation was not affected by the genotype (Fig. 10).
, 百拇医药
Transmitter release overflow was evaluated in acute atrium preparations from 6-day-old animals upon preloading with [3H]NA as described in Methods. The figure shows basal overflow, overflow induced by electrical field stimulation (120 pulses, 3 Hz), and the overflow in response to 100 μM nicotine in the presence of 0.5 μM TTX. Data points are the mean overflow ± S.E.M. from nine (wild-type) or 12 (knockout) atria. Transmitter overflow induced by nicotine was significantly larger in 5 (–/–) compared to 5 (+/+) animals (P < 0.01). Basal and electrically induced overflow did not differ significantly between preparations obtained from either knockout or wild-type animals (P > 0.05).
, 百拇医药
Discussion
Prior studies demonstrate distinct pharmacological properties of somatic–dendritic versus axonally targeted nAChRs of rat SCG neurones in vitro (Kristufek et al. 1999). The current study extends these observations by initiating a systematic analysis of the potential role of nAChR subunit composition in distinct receptor pools, using mice with targeted deletions of individual nAChR subunits (for reviews see Wang et al. 2002b; Champtiaux & Changeux, 2004; Dajas-Bailador & Wonnacott, 2004). In particular, this study explores the role of 5 subunits, testing whether pharmacological differences between somato-dendritic versus presynaptic nAChRs may be due, at least in part, to the distinct role of the 5 subunit in nAChRs in different neuronal domains.
, 百拇医药
The simplest summary of these combined genetic and pharmacological analyses is that 5 nAChR subunits differentially contribute to nAChR pools in different cellular locales. The most intriguing and unexpected finding from our results is the enhancement of presynaptic nAChR-mediated NA release consequent to the deletion of 5 subunits from axonally targeted nAChRs. The implications of these findings are discussed below.
Overall, we provide three new observations regarding the profile of nAChRs expressed by mouse SCG neurones in general and the contributions of the 5 nAChR subunit in particular: (1) the pharmacological profile of somatic nAChRs depends on developmental age and on the presence or absence of 5 subunit gene expression; (2) the pharmacological profile of presynaptic nAChRs differs from that of the somatic nAChRs by being independent of developmental age and of 5 subunit gene expression; and (3) the effects of 5 deletion are most evident in changes of presynaptic nAChRs, implicating 5 subunits in constraining the number and/or efficacy of nAChRs linked to the presynaptic facilitation of NA release. Complementary studies in more intact (acute atrium) preparations confirm the hypothesized role of 5 subunits in shaping nicotine-evoked NA release (Fig. 10).
, 百拇医药
Contribution of 5 subunits to somatic nAChRs
Our studies revealed both age- and 5 expression-dependent differences in somatic nAChRs, including significantly higher potency of cytisine compared to DMPP at early stages (1 DIV after removal of ganglia from P4/5 mice), whereas DMPP and cytisine were essentially equipotent after 1 week in vitro. In contrast, in mice lacking the 5-nAChR subunit, somatic nAChRs were described by a rank order potency of DMPP > cytisine irrespective of the age of cultures. These and other data (discussed below, and see McNerney et al. 2000; Skok, 2002; Vincler & Eisenach, 2003; Nai et al. 2003) are consistent with our suggestion that mature somatic nAChRs in mouse SCG include 354* nAChRs as well as 3542* nAChRs.
, 百拇医药
The rat SCG contains mRNA for 3, 5, 7, 2 and 4 (Mandelzys et al. 1995; De Koninck & Cooper, 1995; Zhou et al. 1998; D. Kristufek and S. Huck, unpublished observation). If we assume an identical subunit profile in the mouse, and if we further assume that the deletion of one subunit is not compensated by the appearance or up-regulation of another (see Kedmi et al. 2004), we should be able to assess the contribution of 5 to somatic nAChRs based on the differences in pharmacological profile per se. Elegant studies, using nAChR subunit-specific antibodies, have provided both immunohistochemical and immunoprecipitation-based evidence for the probable composition of peripheral neurone-type nAChRs in chick and human (Conroy & Berg, 1995; Wang et al. 1996; Gerzanich et al. 1998). Although comparable studies have yet to be done in rat or mouse, the prior work on other species, together with data from heterologous expression of known subunit combinations, provide important guidelines for the current study.
, 百拇医药
In the chick ciliary ganglion, most of the 5 gene product in fully assembled receptors is associated with both 3 and 4 subunits. About 20% of these receptors also contain 2 (Conroy & Berg, 1995). The first studies of 5 in heterologous recombination with other and subunits examined 5 plus 4 and 2 subunits from chick (Ramirez-Latorre et al. 1996). The 542* nAChRs had a higher conductance and a faster rate of agonist-induced desensitization than nAChRs formed without 5. Co-transfection of chick 5 with 34 in (human) BOSC 23 cells added an additional, low affinity component (EC50, 512 μM) of ACh-induced currents to the higher-affinity profile (EC50, 66 μM) seen with simple pairwise expression of 3 and 4 (Fucile et al. 1997). These data, and our observations, are in keeping with findings in the chick SCG that functional deletion of the 5 subunit by antisense oligonucleotide treatment removes nAChRs with relatively low affinity to ACh and cytisine (Yu & Role, 1998b). However, cotransfection of chick 5 with 34 in Xenopus oocytes, or of chick 5 with 32 in BOSC 23 cells, had little effect on either the potency or the efficacy of ACh (Fucile et al. 1997).
, 百拇医药
In the human neuroblastoma SH-SY5Y cell line, both 3 and 5 could be copurified by the 2-specific antibody mAb290, implying co-assembly of these three subunits into complexes (Wang et al. 1996). About 50% of 3 receptors also contained 2 (Wang et al. 1996; Gerzanich et al. 1998). Indirect evidence suggests that 4 might substitute for 2 in the remaining receptors (Gerzanich et al. 1998). It is clearly pertinent to interpretation of the current study to consider how the presence of the 5 subunit modifies combinations of 34, 32 and possibly 324 human receptor subunits. This question has been addressed by co-expression of various combinations of cloned human 3, 2, 4 and 5 receptors in Xenopus oocytes (Wang et al. 1996; Gerzanich et al. 1998).
, 百拇医药
The presence of 5 subunits increased both the rate of desensitization and the calcium permeability of receptors containing 32 or 34 (Gerzanich et al. 1998). Agonist efficacies relative to ACh were both enhanced and reduced (e.g. for nicotine or cytisine, respectively, at receptors containing 32). Moreover, the presence of 5 dramatically enhanced the potency of agonists at receptors including 32, and to a lesser extent at 34 containing receptors. Expression of all four subunits 3, 2, 4 and 5 resulted in complex concentration–response relations for ACh and DMPP that were fitted with the sum of two Hill equations (Gerzanich et al. 1998).
, http://www.100md.com
Overall these studies, like ours, indicate that the inclusion of 5 subunit in nAChR complexes may selectively affect the potency and efficacy of nicotinic agonists. Depending on the age of the preparation, cytisine was either more potent than, or equipotent to, DMPP in activation of somatic receptors in wild-type (WT) mice. The deletion of 5 reversed the potency ratios so that DMPP exceeded cytisine. The simplest interpretation of the changes we observe in somatic nAChRs with and without 5 deletion is that 5 is a more prominent contributor to shaping the profile of nAChRs in more mature neurones.
, http://www.100md.com
The differences in the agonist potency and efficacy at somatic nAChRs with/without 5 subunits reported here, are more subtle than those seen by adding 5 to pairwise subunit combinations of 32 or 34 (or even 42) expressed in oocytes (Ramirez-Latorre et al. 1996; Gerzanich et al. 1998). This may be due to species differences (McGehee & Role, 1995), the choice of the system used to express cloned receptors (Fucile et al. 1997) or additional nAChR subunits that might modify the overt impact of 5. Of particular note are the many studies suggesting that native (somatic) nAChRs are not accurately recapitulated by combinations of two or three known subunits in heterologous expression systems (Covernton et al. 1994; Silvilotti et al. 1997; Lewis et al. 1997).
, 百拇医药
Contribution of 5 subunits to prejunctional/preterminal nAChRs
In contrast to the apparent fine-tuning of the profile of somatic nAChRs, the current study unveiled dramatic effects of 5 expression (or lack thereof) on the extent of nAChR-activated (TTX-resistant) transmitter release. Such findings must be related to the plethora of prior work implicating 5 in modulating the number, profile, rate of desensitization and calcium permeability of comparable pairwise nAChR subunit combinations (delineated above).
, http://www.100md.com
Indeed, measurements of somatic calcium fluxes in the 5 (–/–) revealed slight increases compared with assays in WT mice. One might reason that even such a modest increase may be enough to support a dramatic increase in prejunctional nAChR-mediated NA release as exocytosis can follow calcium concentration to up to the fourth power (Regehr & Stevens, 2001). However, this explanation seems unlikely for three reasons. First, all nAChR agonists were much more effective in stimulating TTX-resistant NA release in 5 (–/–) versus 5 (+/+) animals (i.e. the increased efficacy in activation of prejunctional receptors in 5 (–/–) mice was seen with ACh as well as other agonists). In contrast, the changes in Ca2+ flux at somatic receptors in 5 (+/+) and 5 (–/–) animals were agonist-dependent (e.g. ACh efficacy did not change). Second, even a fourth-power function of the overall increase of the somatic calcium signal (1.144 = 1.69) hardly reaches the magnitude of the observed increase in release detected in the 5 (–/–) mice (2.7-fold greater than 5 (+/+)). Last but not least, our findings vis-à-vis nicotine-induced changes in Ca2+ signals in 5 (+/+) versus 5 (–/–) mice appear to run contrary to predictions derived from prior studies. Thus earlier work had indicated that the exclusion of 5 would be expected to yield nAChRs of lower Ca2+ permeability (Gerzanich et al. 1998), whereas we find that genetic removal of 5 subunit results in the assembly of prejunctional receptors that were nearly 3-fold more efficacious in stimulating Ca2+-dependent NA release.
, 百拇医药
We propose two possible mechanisms to explain how altering the expression of 5 nAChR subunits might regulate the extent of prejunctional nAChR-mediated NA release from sympathetic neurones: (1) 5-containing nAChRs, although somewhat higher in Ca2+ permeability, are less efficiently coupled to calcium-induced calcium release (CICR) from internal stores and thus less efficacious in stimulation NA release; and (2) the synthesis and incorporation of 5 into nAChRs decreases the assembly and/or insertion of non-5-containing nAChR complexes, thus decreasing the overall number of functional nAChRs within the axon terminal domain. Arguments pertinent to these models are discussed below.
, http://www.100md.com
Coupling of 5 (+/+) versus 5 (–/–) prejunctional nAChRs to CICR and NA release
Several recent studies have emphasized the contribution of CICR to the mechanism(s) underlying the coupling of activation of presynaptic nAChRs to increased exocytosis (e.g. Shoop et al. 2001; Brain et al. 2001; Dajas-Bailador et al. 2002; Girod et al. 2003; Sharma & Vijayaraghavan, 2003; for review see Dajas-Bailador & Wonnacott, 2004). Accordingly, CICRs appear to play an important role in more sustained aspects (many minutes) of nicotine-evoked changes in Ca2+ signalling (for review see Dajas-Bailador & Wonnacott, 2004). As 5-containing receptors have greater rates and amounts of desensitization (e.g. Ramirez-Latorre et al. 1996; Gerzanich et al. 1998), nAChRs that do not include the 5 subunit might be more effectively coupled to enhanced release due to differences in the time course and extent of changes in local Ca2+ influx, and hence in CICR activation. Thus a more transient increase Ca2+ influx might be less effective in stimulating CICR, even if the surge in local Ca2+ concentration were greater in magnitude (e.g. Shoop et al. 2001; Brain et al. 2001; Dajas-Bailador et al. 2002; Girod et al. 2003; Sharma & Vijayaraghavan, 2003; for review see Dajas-Bailador & Wonnacott, 2004). However, it is not clear whether such a mechanism, though feasible, would be sufficiently different in coupling to CICR to explain the remarkable enhancement of transmitter release seen in the 5 (–/–) animals.
, 百拇医药
Role of 5 subunit gene expression in regulating the number of prejunctional nAChRs
Several investigators have underscored the effects of 5 co-expression on the overall number of functional surface nAChRs. Thus, BOSC 23 cells transfected with 34 show a reduction in the number of nicotine-responsive cells and of the maximum inducible current upon cotransfection with 5 (Fucile et al. 1997). Likewise, the number of membrane-incorporated 32 receptors detected by [125I]mAb210 is about halved if cotransfected with 5 in Xenopus oocytes (Wang et al. 1996). According to this view the presence or absence of the 5 subunit may affect the number nAChRs on the cell surface, rather than influencing the properties of individual receptors.
, http://www.100md.com
One mechanism whereby increased expression of 5 subunits might be expected to decrease the number of surface nAChRs is suggested by sucrose gradient centrifugation and Western blot analysis by (Wang et al. 1996). These investigators suggest that the formation of 325 (and possibly 345*) nAChRs, may first require the interaction of 2 with 5 prior to the co-assembly with 3 (Wang et al. 1996). This process may affect the kinetics of the assembly and/or the membrane incorporation of 5-containing nAChRs. This hypothesis, like the CICR coupling concept presented above would require that somatic and prejunctional receptors are differentially affected by the expression of 5 in order to account for the observations in the present study.
, http://www.100md.com
In conclusion, our experiments show that deletion of the 5-nAChR subunit differentially affects somatic and prejunctional nAChRs in mouse SCG neurones. An important role of 5 subunits in determining the efficacy of nAChRs that facilitate action potential independent NA release is demonstrated. Despite these insights, we are not yet able to accurately predict the subunit composition of the nAChRs at the two different sites. However, ongoing experiments with mice lacking additional subunits, combined applications of the RNAi technique for deletion of selected subunits and immunolocalization studies with subunit-specific antibodies should soon permit identification of the and subunits that assemble into somatic and prejunctional receptors, respectively.
, 百拇医药
References
Boehm S & Huck S (1995). 2-Adrenoreceptor-mediated inhibition of acetylcholine-induced noradrenaline release from rat sympathetic neurons: an action at voltage-gated Ca2+ channels. Neuroscience 69, 221–231.
Brain KL, Trout SJ, Jackson VM, Dass N & Cunnane DC (2001). Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores. Neuroscience 106, 395–403.
, 百拇医药
Champtiaux N & Changeux J-P (2004). Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog Brain Res 145, 235–251.
Conroy WG & Berg DK (1995). Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J Biol Chem 270, 4424–4431.
Conroy WG, Liu Z, Nai Q, Coggan JS & Berg DK (2003). PDZ-containing proteins provide a functional postsynaptic scaffold for nicotinic receptors in neurons. Neuron 38, 759–771.
, http://www.100md.com
Conroy WG, Ogden LF & Berg DK (2000). Cluster formation of 7-containing nicotinic receptors at interneuronal interfaces in cell culture. Neuropharmacology 39, 2699–2705.
Covernton PJO, Kojima H, Silvilotti LG, Gibb AJ & Colquhoun D (1994). Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J Physiol 481, 27–34.
Cuevas J, Roth AL & Berg DK (2000). Two distinct classes of functional 7-containing nicotinic receptor on rat superior cervical ganglion neurons. J Physiol 525, 735–746.
, http://www.100md.com
Dajas-Bailador FA, Mogg AJ & Wonnacott S (2002). Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores. J Neurochem 81, 606–614.
Dajas-Bailador FA & Wonnacott S (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25, 317–324.
De Koninck P & Cooper E (1995). Differential regulation of neuronal nicotinic ACh receptor subunit genes in cultured neonatal rat by sympathetic neurons: Specific induction of 5 by a Ca2+/calmodulin-dependent kinase pathway. J Neurosci 15, 7966–7978.
, 百拇医药
DeLean A, Munson PJ & Rodbard D (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235, E97–E102.
Devay P & McGehee DS, Yu, CR & Role LW (1999). Target-specific control of nicotinic receptor expression at developing interneuronal synapses in chick. Nat Neurosci 2, 528–534.
Fucile S, Barabino B, Palma E, Grassi F, Limatola C, Mileo AM, Alema S & Ballivet M (1997). 5 Subunits forms functional 345 nAChRs in transfected human cells. Neuroreport 8, 2433–2436.
, 百拇医药
Gerzanich V, Wang F, Kuryatov A & Lindstrom J (1998). 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal 3 nicotinic receptors. J Pharmacol Exp Ther 286, 311–320.
Girod R, Jareb M, Moss J & Role LW (2003). Mapping of presynaptic nicotinic acetylcholine receptors using fluorescence imaging of neurite calcium. J Neurosci Methods 122, 109–122.
Groot-Kormelink PJ, Boorman JP & Silvilotti LG (2001). Formation of functional 345 human neuronal nicotinic receptors in Xenopus oocytes: a reporter mutation approach. Br J Pharmacol. 134, 789–796.
, http://www.100md.com
Groot-Kormelink PJ, Luyten WHML, Colquhoun D & Sivilotti LG (1998). A reporter mutation approach shows incorporation of the "orphan" subunit 3 into a functional nicotinic receptor. J Biol Chem 273, 15317–15320.
Grynkiewicz G, Poenie M & Tsien RY (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440–3450.
Krauss KR, Carpenter DO & Kopin IJ (1970). Acetylcholine-induced release of norepinephrine in the presence of tetrodotoxin. J Pharmacol Exp Ther 173, 416–421.
, http://www.100md.com
Kristufek D, Rudorfer W, Pifl C & Huck S (2002). Organic cation transporter (OCT) mRNA and function in the rat superior cervical ganglion. J Physiol 543, 117–134.
Kedmi M, Beaudet AL & Orr-Urtreger A (2004). Mice lacking neuronal acetylcholine receptor 4-subunit and mice lacking both 5- and 4-subunits are highly resistant to nicotine-induced seizures. Physiol Genomics 17, 221–229.
Kristufek D, Stocker E, Boehm S & Huck S (1999). Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles. J Physiol 516, 739–756.
, http://www.100md.com
Lewis TM, Harkness PC, Silvilotti LG, Colquhoun D & Millar NS (1997). The ion channel properties of rat recombinant neuronal nicotinic receptor are dependent on the host cell type. J Physiol 505, 299–306.
McGehee DS & Role LW (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57, 521–546.
McNerney ME, Pardi D, Pugh PC, Nai Q & Margiotta JF (2000). Expression and channel properties of -bungarotoxin-sensitive acetylcholine receptors on chick ciliary and choroid neurons. J Neurophysiol 84, 1314–1329.
, 百拇医药
Mandelzys A, De Koninck P & Cooper E (1995). Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic receptor subunits. J Neurophysiol 74, 1212–1221.
Nai Q, McIntosh JM & Margiotta JF (2003). Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function. Mol Pharmacol 63, 311–324.
Nelson ME & Lindstrom J (1999). Single channel properties of human 3 AChRs: impact of 2, 4 and 5 subunits. J Physiol 516, 657–678.
, 百拇医药
Nelson ME Wang F, Kuryatov A, Choi CH, Gerzanich V & Lindstrom J (2001). Functional properties of nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of 34 AChRs expressed in permanently transfected HEK cells. J Gen Physiol 118, 563–582.
Rae J, Cooper K, Gates P & Watsky M (1991). Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37, 15–26.
Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A & Role LW (1996). Functional contributions of 5 subunit to neuronal acetylcholine receptor channels. Nature 380, 347–351.
, http://www.100md.com
Regehr WG & Stevens CF (2001). Physiology of synaptic transmission and short-term plasticity. In Synapses, ed. Cowan WM, Südhof TC & Stevens CF, pp. 135–175. The Johns Hopkins University Press, Baltimore & London.
Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R & De Biasi M (2003). The nicotinic acetylcholine receptor subunit 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 63, 1059–1066.
, http://www.100md.com Sharma G & Vijayaraghavan S (2003). Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron 38, 929–939.
Shoop RD, Chang KT, Ellisman MH & Berg DK (2001). Synaptically driven calcium transients via nicotinic receptors on somatic spines. J Neurosci 21, 771–781.
Silvilotti LG, McNeil DK, Lewis TM, Nassar MA, Schoepfer R & Colquhoun D (1997). Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J Physiol 500, 123–138.
, http://www.100md.com
Skok VI (2002). Nicotinic acetylcholine receptors in autonomic ganglia. Auton Neurosci 97, 1–11.
Vincler MA & Eisenach JC (2003). Immunocytochemical localization of the 3, 4, 5, 7, 2, 3 and 4 nicotinic acetylcholine receptor subunits in the locus coeruleus of the rat. Brain Res 974, 25–36.
Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K & Lindstrom J (1996). Assembly of human neuronal nicotinic receptor 5 Subunits with 3, 2, and 4 subunits. J Biol Chem 271, 17656–17665.
, 百拇医药
Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R & Korczyn AD (2004). Nicotinic acetylcholine receptor 5 subunits modulate oxotremorine-induced salivation and tremor. J Neurol Sci 222, 87–91.
Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R, Nachmann R & Korczyn AD (2002a). Autonomic function in mice lacking 5 neuronal nicotinic acetylcholine receptor subunit. J Physiol 542, 347–354.
Wang N, Orr-Urtreger A & Korczyn AD (2002b). The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice. Prog Neurobiol 68, 341–360.
, 百拇医药
Williams BM, Temburni MK, Levey MS, Bertrand S, Bertrand D & Jacob MH (1998). The long internal loop of the 3 subunit targets nAChRs to subdomains within individual synapses on neurons in vivo. Nat Neurosci 1, 557–562.
Yu CR & Role LW (1998a). Functional contribution of the 7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones. J Physiol 509, 651–665.
Yu CR & Role LW (1998b). Functional contribution of the 5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurones. J Physiol 509, 667–681.
Zhou Y, Deneris E & Zigmond RE (1998). Differential regulation of levels of nicotinic receptor subunit transcripts in adult sympathetic neurons after axotomy. J Neurobiol 34, 164–178., 百拇医药(Harald Fischer, Avi Orr-U)
2 The Genetic Institute, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, 6 Weizmann Street, Tel Aviv 64239, Israel
3 Center for Neurobiology and Behavior, College of Physicians and Surgeons, Columbia University, 722 West 168th Street, Research Annex Room 807, New York, NY 10032, USA
, 百拇医药
Abstract
We have compared the functional properties of nicotinic acetylcholine receptors (nAChRs) within both somatic and presynaptic domains of superior cervical ganglion (SCG) neurones from wild-type (WT) mice with those expressed by SCG neurones from mice with a targeted deletion of the gene for the 5-subunit. The functional profile of somatic nAChRs was assayed by direct macroscopic current recording and from measurements of nicotinic agonist-induced calcium transients with fura-2 imaging. The profile of nAChRs at presynaptic sites was assayed by measurement of nicotinic agonist-induced transmitter release (as preloaded [3H]noradrenaline) under conditions of action potential blockade. We have examined the responses to the nicotinic agonists acetylcholine, nicotine, cytisine, dimethylphenylpiperazinium iodide (DMPP) and epibatidine. Macroscopic current and calcium imaging assays revealed several differences in the functional profile of somatic nAChRs in WT SCG neurones compared with those from mice with the 5 subunit deleted. Somatic nAChRs in control animals were more potently activated by cytisine as compared to DMPP. In contrast, DMPP was consistently more potent than cytisine in mice lacking the 5 nAChR subunit. Differences in the somatic nAChR rank order of potency were most prominent after a least 1 day in vitro. The magnitude of somatic nAChR responses to nicotinic agonists was not substantially different in control mice compared with those of 5 subunit-deleted animals. Comparison of presynaptic nAChR-mediated responses in WT versus 5 subunit-deleted animals revealed a very different set of changes in the functional profile of prejunctional nAChRs compared with somatic nAChRs. In contrast to somatic nAChRs, the responses of prejunctional receptors were markedly enhanced in 5 knockout animals compared with control. Furthermore, all prejunctional receptor responses were most potently activated by DMPP in both control and in 5 subunit-deleted mice. Hence, the presence or absence of the 5 subunit did not affect the rank order of potency of agonists at preterminal sites but greatly affected the magnitude of presynaptic nAChR-mediated responses. The enhanced efficacy of nicotine at presynaptic receptors was corroborated in an acute atrium preparation from postnatal 5 subunit-deleted mice. These results confirm and significantly extend our previous observation that in the sympathetic nervous system, somatic and prejunctional receptors are different and rely on the presence of the 5 subunit in a distinct manner.
, 百拇医药
Introduction
Neuronal-type nicotinic acetylcholine receptors (nAChRs) play a pivotal role in trans-ganglionic signal transduction of the vegetative; nervous system (Wang et al. 2002b). The properties of these receptors have been studied extensively in the cholinergic (chick) ciliary ganglion (Williams et al. 1998; Conroy et al. 2000; Conroy et al. 2003), and in the chick (Yu & Role, 1998a,b; Devay et al. 1999) and rodent (Covernton et al. 1994; Silvilotti et al. 1997; Kristufek et al. 1999; Cuevas et al. 2000) sympathetic nervous system (for review see Skok, 2002).
, 百拇医药
The principal subunits that make up nAChRs in the vegetative nervous system are 3 and 4 (McGehee & Role, 1995; Skok, 2002). In heterologous expression systems these two subunits are sufficient to form functional receptors (reviewed by McGehee & Role, 1995). However, RT-PCR analysis, measurements of ligand binding, reported effects of -bungarotoxin, and studies of subunit-specific antibodies indicate the presence of 5, 7, 2 and possibly 4 subunits in rodent superior cervical ganglion (SCG) (Skok, 2002). The inclusion of 5, 7 and 2 nAChR subunits into ganglionic 3/4 pairs would be expected to change the functional profile of these receptors (Wang et al. 1996; Ramirez-Latorre et al. 1996; Groot-Kormelink et al. 1998; Gerzanich et al. 1998; Yu & Role, 1998a,b; Nelson & Lindstrom, 1999; Cuevas et al. 2000; Groot-Kormelink et al. 2001; Nelson et al. 2001; Nai et al. 2003).
, 百拇医药
Prior studies of the functional properties of nAChRs expressed by noradrenergic sympathetic or SCG neurones have primarily focused on receptors at somatic sites (Covernton et al. 1994; Mandelzys et al. 1995; Silvilotti et al. 1997; Yu & Role, 1998a,b). However, ganglionic neurones also have presynaptic (or prejunctional) nAChRs that are located on their axonal projections within the various target organs (Brain et al. 2001). Agonist-induced activation of these presynaptic nAChRs may generate antidromic volleys and cause the release of noradrenaline (Krauss et al. 1970).
, 百拇医药
We have previously shown (Kristufek et al. 1999) that prejunctional receptors are more sensitive to the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), whereas somatic receptors in cultured rat SCG neurones are more potently activated by cytisine (Covernton et al. 1994; Kristufek et al. 1999). The distinct pharmacological profiles of somatic versus presynaptic nAChRs indicates fundamental differences in these receptor populations that may be due, at least in part, to differences in the subunit composition of the receptors (McGehee & Role, 1995; Nai et al. 2003). Attempts to dissect the subunit composition of these distinct receptors by comparing the properties of native receptors with receptors of defined composition expressed in heterologous systems have been less than successful in assigning a particular set of subunits that correspond to the functional profiles of rat SCG nAChRs (Covernton et al. 1994; Silvilotti et al. 1997; Lewis et al. 1997).
, 百拇医药
We have chosen a somewhat different tactic to the analysis of native subunit composition, examining the ‘pharmacological fingerprints’ (Covernton et al. 1994; Kristufek et al. 1999) of both somatic and prejunctional nAChRs in neurones from mice with functional deletions of a particular subunit (Champtiaux & Changeux, 2004). This report, as first part in a series of experiments, deals with studies on nicotinic receptors in the SCG from mice with a targeted deletion of the 5 subunit (Wang et al. 2002a,b, 2004; Salas et al. 2003). The general behaviour and gross anatomy of 5 knockout mice are similar to their wild-type littermates (reviewed by Wang et al. 2002b). However, 5 knockout mice are, for example less susceptible to nicotine-induced seizure (Kedmi et al. 2004), have more severe symptoms in experimental colitis (A. Orr-Urtreger, manuscript in preparation), and show an altered cardiac parasympathetic ganglionic transmission (Wang et al. 2002a). For a better understanding of the role of the 5 subunit in ganglionic transmission, the effects of 5 deletion now presented encourage one to take a second look for specific effects of nicotine in such mice.
, 百拇医药
Methods
Animals
Experiments were performed on cell cultures of dispersed SCG neurones or on acute atrial preparations taken from early postnatal mice with 5 subunit deficiency (5 –/–) on C57BL/6J background and their wild-type (5+/+) littermates (Salas et al. 2003).
Cell culture
Superior cervical ganglia were dissected from 4- to 6-day-old mouse pups humanely killed, as required by the Guidelines of the Animal Care Committee, by decapitation. The ganglia were dispersed to single cells, and plated as previously described (Boehm & Huck, 1995). Briefly, ganglia were freed from adhering connective tissue and blood vessels and incubated in a combination of collagenase IA (0.5 mg ml–1, Sigma) and dispase (1.0 mg ml–1, Roche Applied Science) for 20 min at 36.5°C. Subsequently, the ganglia were rinsed three times in Ca2+-free Tyrode solution and trypsinized (0.25% trypsin in Tyrode solution; Worthington) for 15 min at 36.5°C and dispersed by trituration in culture medium. Dispersed neurones were plated either onto 5-mm discs punched out of tissue culture dishes (Nunc) for experiments measuring transmitter release, or onto glass coverslips (Assistent) for patch-clamp recordings and fura-2 spectrofluorometry. Glass coverslips were treated by submersion in concentrated nitric acid for 2 days and thorough rinses thereafter with distilled water. Tissue culture discs and cleaned glass coverslips were coated with poly L-ornithine (100 mg (l H2O)–1; Sigma), followed by 250 μl laminin (Becton Dickinson; dissolved as 0.01 g l–1 in Neurobasal A medium, Gibco-Invitrogen). Approximately, 7500 cells were seeded into glass rings of 6 mm (release experiments) or 8 mm (patch clamp and calcium imaging) in order to confine them to the disc or the centre of the coverslip.
, 百拇医药
The culture medium consisted of Neurobasal A medium, supplemented with the B-27 additive (20 ml l–1; Gibco-Invitrogen), 25000 IU l–1 penicillin, 25 mg l–1 streptomycin (Gibco-Invitrogen), 0.5 mM L-glutamine (Sigma) and 20–50 μg l–1 nerve growth factor (NGF; R & D Systems).
Cultures meant for release experiments were maintained in the presence of 5% fetal bovine serum (Gibco-Invitrogen) and in 5% CO2, whereas the serum-free cultures used for calcium imaging and patch-clamp recordings were kept in 7% CO2.
, 百拇医药
Spectrofluorometry: fura-2 calcium imaging
Measurements of intracellular Ca2+ concentrations were performed at room temperature on an inverted Nikon Diaphot 300 microscope connected to a spectrofluorometrical calcium imaging system (VisiTech, Sunderland, UK). Cells on glass coverslips were ‘loaded’ with dye by incubation in culture medium including 5 μM acetoxymethyl ester form of fura-2 (fura-2 AM Molecular Probes). Preparations were rinsed twice with bathing solution prior to transfer to a recording chamber. The bathing (external) solution used for both calcium imaging and for patch-clamp analysis contained (mM): NaCl 120, KCl 3.0, CaCl2 2.0, MgCl2 2.0, glucose 20 and Hepes 10; adjusted to pH 7.3 with NaOH, and a final osmolarity of 280 mosmol l–1.
, http://www.100md.com
Changes in intracellular Ca2+ concentrations were determined by dual excitation at 340 and 380 nm, and by measuring emission at 510 nm. Measured F340/F380 ratios were transformed into Ca2+ concentration by the eqn (1) of Grynkiewicz (Grynkiewicz et al. 1985):
where Rmin = Sf1/Sf2; Rmax = Sb1/Sb2; Keff = KD x Sf2/Sb2. [Ca2+] is the calculated calcium concentration; Rmin the calibration constant for F340/F380 ratio at zero free calcium; Rmax the calibration constant F340/F380 ratio for 39.8 μM free calcium; R the actually measured F340/F380 ratio; Sf1 the F340 determined by calibration with zero free calcium buffer; Sf2 the F380 determined by calibration with zero free calcium buffer; Sb1 the F340 determined by calibration with 39.8 μM free calcium buffer; Sb2 the F380 determined by calibration with 39.8 μM free calcium buffer; Keff the calibration constant; and KD the dissociation constant for fura-2 (224 nM at room temperature Grynkiewicz et al. 1985). The Keff, Rmin and Rmax calibration constants were determined for a given setting by measuring fura-2 fluorescence intensities in the absence or presence of 39.8 μM free calcium (Calcium Calibration Set, Molecular Probes).
, 百拇医药
Excitation light from a monochromatic fluorescent light source (QuantiCell FSM900, VisiTech) was directed to the sample via an appropriate filter set (Omega). Images were taken with a Nikon Fluor 40x/1.3 Ph4DL oil immersion objective and an intensified CCD camera (Stanford Photonics XR/Mega10 GEN III +). Registration of F340/F380 ratio images was at 1 Hz and controlled by the QuantiCell 2000 software (version 2.0e; VisiTech). We determined the Ca2+ concentrations in single cells off-line by selecting areas of interest from images recorded while applying our test substances. The effects of drugs were assessed by calculating the peak increase in intracellular calcium from baseline values. Nicotinic agonists were dissolved in recording buffer and applied in the presence of 0.5 μM tetrodotoxin (TTX, Latoxan) by a superfusion device (DAD-12, Adams & List) at a rate of one concentration per minute. Application times were adjusted to the occurrence of peak effects (12 s for low concentrations, 6 s for high concentrations of agonists).
, 百拇医药
Simultaneous calcium imaging and perforated-patch voltage-clamp recordings
Neurones loaded with fura-2 AM as described above were also assayed by electrophysiological recordings using perforated patch-clamp techniques (Rae et al. 1991). The recording pipettes had tip resistances of 1.5–3 M when filled with 200 μg ml–1 amphotericin B (Sigma A-4888) in a standard internal solution containing (mM): K2SO4 75, KCl 55, MgCl2 8, Hepes 10, adjusted to pH 7.3 with (KOH). Cells were voltage clamped at –70 mV. For signal processing we used an Axopatch 200A (Axon Instruments) patch-clamp amplifier, a Digidata 1200 (Axon Instruments) A/D converter, and the pCLAMP 8 software (Axon Instruments).
, 百拇医药
[3H]Noradrenaline uptake and superfusion
The techniques for loading cultures with [3H]noradrenaline (NA) and subsequent superfusion for measurement of [3H]NA release were as previously described (Kristufek et al. 1999). Briefly, the cultures were incubated with 0.03 μM [3H]NA in culture medium containing 1 mM ascorbic acid for 60 min at 36.5°C. Culture discs were then transferred to low-volume chambers and superfused at 25°C with buffer containing (mM): NaCl 120, KCl 3, CaCl2 2, MgCl2 2, glucose 20, Hepes 10, fumaric acid 0.5, sodium pyruvate 5.0 and ascorbic acid 0.57; adjusted to pH 7.4 with NaOH. The rate of superfusion was 1 ml min–1, and superfusate was collected in 4-min samples before a 60-min washout period. Residual radioactivity within preparations after the release procedures was determined by extracting cultures at the end of an experiment with 1% sodium dodecyl sulphate (SDS). Radioactivity in extracts and collected fractions was determined by liquid scintillation counting.
, 百拇医药
Stimulation-induced radioactive outflow was achieved by adding nicotinic agonists to the superfusion medium for 15 s. Cultures were challenged with a first stimulus (S1) 12 min after the washout period (i.e. 72 min after initiation of superfusion) and to a maximum of three additional stimuli (S2, S3 and S4) at 20 min intervals. Concentration–response relationships for nicotinic agonists were established by a measuring a maximum of four stimuli with increasing concentrations of the agents in the absence or continuous presence of 0.25 μM TTX.
, 百拇医药
Mouse atria were taken from 6-day-old pups killed by decapitation and collected in ice-cold superfusion buffer containing (mM): NaCl 118, KCl 4.8, CaCl2 2.5, MgSO4 1.2, NaHCO3 25, KH2PO4 1.2, Na2-EDTA 0.03, glucose 11, ascorbic acid 0.57, fumaric acid 0.5 and sodium pyruvate 5.0; and bubbled with 95%O2–5%CO2. Loading of radioactivity was achieved by adding 0.03 μM [3H]NA and 1 mM ascorbic acid to superfusion buffer and incubating atria for 60 min at 36.5°C. One intact atrium was placed thereafter into each chamber and rinsed with superfusion buffer for 60 min before samples were collected at 4 min intervals. In order to block monocemine oxidase A (MAOA) activity and thus reduce the basal outflow of radioactivity, atria were exposed to 0.5 μM clorgyline for 20 min during the initial washout period (Kristufek et al. 2002). Stimulation-induced outflow of [3H]NA was achieved by either electrical field stimulation (120 monophasic pulses delivered at 3 Hz, 0.5 ms, 50 V cm–1, 40 mA), or by adding 100 μM nicotine (in the presence of 0.5 μM TTX) for 15 s to the superfusion buffer. Residual radioactivity was determined by extracting atria at the end of an experiment with 1% SDS and sonication.
, http://www.100md.com
Calculation of basal and stimulation-evoked [3H]NA outflow
Rates of [3H]NA outflow were obtained by dividing the amount of [3H]NA collected during a 4-min period by the total [3H]NA content of cultures at the beginning of the corresponding 4-min collection period (expressed as fractional rate). Basal outflow before the first stimulus (i.e. the basal fractional rate) was termed L1. Stimulation-evoked outflow was calculated as the difference between the total [3H]NA outflow during and after stimulation on the one hand, and the estimated basal outflow on the other hand, assuming that basal release follows a linear decline (Kristufek et al. 1999). The (stimulus-induced) difference was expressed as a percentage of the total radioactivity in the cultures at the beginning of the respective stimulation (S%, see Kristufek et al. 1999).
, http://www.100md.com
Calculation of concentration–response curves and potency ratios
All data are presented as arithmetic means ± S.E.M. The significance of differences was evaluated by means of the unpaired Student's t-test, unless indicated otherwise. Raw data from fura-2 imaging, patch-clamp recordings, and transmitter release experiments were converted into concentration–response curves using self-written script files for SigmaPlot 2000 (SPSS Inc.). Full concentration–response curves for agonists were fitted by unweighted non-linear regression to the logistic equation:
, 百拇医药
where Ex is the response to a certain agonist concentration; x the arithmetic dose; Emax the maximal response; p a slope factor; and EC50 the dose that gives a half-maximal response. Computation utilized either SigmaPlot 2000 (SPSS Inc.) or the ALLFIT program (DeLean et al. 1978). The ALLFIT program calculates parameter estimates for EC50 values, the slope p (which is numerically identical to the Hill coefficient, see DeLean et al. 1978), and Emax, as well as appropriate standard errors and leaves the option to fit curves with or without shared parameters by non-linear regression. The program uses F statistics as the ‘extra sum of squares’ introduced when testing for independent versus shared parameters of two curves.
, 百拇医药
Low-concentration potency ratios were determined according to Covernton et al. (Covernton et al. 1994; Kristufek et al. 1999). Hence, dose–response curves (at the low-concentration end) were fitted simultaneously by non-linear regression with logistic equations that were constrained to be parallel (i.e. with a shared slope parameter, p). The maximum response was fixed to values deduced from full-range concentration–response curves of previous experiments. Adequacy of the fits was judged by eye (e.g. see Figs 2 and 8).
, 百拇医药
Examples are shown from one of the three 5 (+/+) neurones successfully assayed with both calcium imaging and whole cell current recording to assess the effects of agonist at the low end of the concentration–response curve. A, calcium transients, concurrently determined with whole-cell currents, in response to 12-s applications (indicated by bars) of nicotine, cytisine, DMPP or ACh (in the presence of 0.1 μM atropine). Concentrations were 3, 5 and 10 μM (nicotine, cytisine and DMPP, respectively), and 5 and 10 μM (ACh). Sharp deviations in current traces are due to the CCD camera shutter. The experiment was conducted on a 4 DIV preparation. B, dose–response relationship of peak calcium transients constructed from original recordings as shown in A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine (Cyt); dashed lines and open symbols are effects of DMPP (), nicotine (Nic, ) and ACh (). Potency ratios relative to cytisine (1.0) were 0.75 (DMPP), 0.51 (nicotine) and 0.39 (ACh). C, dose–response relationship of peak currents constructed from original recordings as shown in panel A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine; dashed lines and open symbols are effects of DMPP (), nicotine () and ACh (). Potency ratios relative to cytisine (1.0) were 0.81 (DMPP), 0.63 (nicotine) and 0.48 (ACh).
, http://www.100md.com
A1, transmitter release was evaluated in preparations of SCG obtained from 5 (+/+) mice at 5 DIV that were preloaded with [3H]NA as described in Methods. Responses to DMPP () and cytisine () in the presence of 0.25 μM TTX are shown. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Triangles and continuous line show the concentration–response curve for cytisine; dashed line and squares are effects of DMPP. In this assay, the potency of DMPP exceeded cytisine by a factor of 2.33 ± 0.03 (n = 3 individual cultures). This experiment, done in triplicate with 5 DIV cultures, yielded a mean potency ratio of 2.12 ± 0.16 (n = 9 cultures; see B1). A2, same experimental protocol as shown in A1, except that transmitter release was determined in 5 DIV cultures obtained from 5 (–/–) mice. The potency of DMPP exceeded cytisine by a factor of 2.39 ± 0.12 (n = 3 individual cultures). This experiment, done in triplicate with 5 DIV cultures, yielded a mean potency ratio of 2.00 ± 0.11 (n = 9 cultures; see B2). B1, time course of potency ratios determined in preparations of SCG obtained from 5 (+/+) mice after 2, 5 and 8 DIV. For each time point, the effects of DMPP and cytisine were determined in at least three release experiments similar to the one shown in A1. B2, time course of potency ratios determined in preparations of SCG obtained from 5 (–/–) mice after 2, 5 and 8 DIV. For each time point, the effects of DMPP and cytisine were determined in at least three release experiments similar to the one shown in A2.
, 百拇医药
Materials
Materials and reagents were obtained as noted and from the following sources: (–)-[ring-2,5,6 3H]noradrenaline (56.9 Ci mmol–1, NEN); acetylcholine chloride (ACh), 1,1,-dimethyl-4-phenylpiperazinium iodide (DMPP) cytisine, epibatidine and clorgyline hydrochloride from Sigma; and all other chemicals were from Merck (analytical grade).
Results
In the current series of experiments we established pharmacological fingerprints of somatic and prejunctional receptors in cultured SCG neurones by comparing the responses to five established nicotinic agonists: nicotine, cytisine, DMPP, ACh and epibatidine. Due to the relatively high calcium permeability of neuronal-type nAChRs, as compared with their muscle nAChR cousins (reviewed by McGehee & Role, 1995), the properties of receptors at somatic sites could also be assessed by spectrofluorometry using the Ca2+-sensitive dye, fura-2, in addition to patch-clamp recording. As in our previous study (Kristufek et al. 1999), functions of prejunctional receptors were monitored by measuring the outflow of preloaded [3H]NA as a result of calcium influx at sites of transmitter release. Generation of action potentials, and ensuing calcium entry through voltage-gated calcium channels, was prevented by adding TTX to the buffer solutions. We have shown previously that under these conditions, nicotinic agonists are unable to depolarize SCG varicosities sufficient for an activation of high voltage-activated calcium channels (Kristufek et al. 1999).
, 百拇医药
Somatic nAChRs: assessment of function by full concentration–response curves of nicotinic agonists and differences in rank order of potency between 5 (+/+) and 5 (–/–) mice
An assessment of potencies of nicotinic agonists by calcium imaging using fura-2, and deduced from full concentration–response curves in 5 (+/+) mouse SCG neurones after 4–5 days in vitro (DIV) (4/5 DIV) produced results very similar to patch-clamp observations previously made in the rat SCG (Covernton et al. 1994; Kristufek et al. 1999). Hence, out of the four classical agonists, cytisine was most potent to activate somatic receptors, followed by DMPP, nicotine and ACh (in the presence of 0.1 μM atropine; Fig. 1; Table 1). Potency ratios calculated from EC50 values (Table 1) relative to the standard cytisine (1.0) were 0.80 (DMPP), 0.64 (nicotine) and 0.26 (ACh). These values are strikingly close to those obtained in rat (DMPP, 0.62; nicotine, 0.60; Ach, 0.34; all relative to cytisine Kristufek et al. 1999). In all assays presented in our present study, the potency of epibatidine exceeded the most potent concurrent nicotinic agonist by at least three orders of magnitude (Figs 1 and 7, and Table 1 and 2).
, 百拇医药
A–E, calcium transients in the soma region were recorded by fura-2 calcium imaging in response to DMPP (A), cytisine (B), nicotine (C), ACh (in the presence of 0.1 μM atropine, D) and epibatidine (E). Recordings were done in the presence of 0.5 μM TTX. Full concentration–response curves for each of the agonists were determined in at least 20 neuronal somata of two to three different preparations of control or of 5 (–/–) neurones (4–5 DIV). Values of individual cells were normalized with respect to the concentrations yielding maximum response (DMPP and nicotine, 67 μM; cytisine and Ach, 200 μM; epibatidine, 67 nM), and then fitted for determination of EC50 values using eqn (2). Results from 5 (+/+) animals are indicated by filled symbols and continuous lines, those from 5 (–/–) by open symbols and dashed lines. Fitted parameters are summarized in Table 1. There were only minor differences in EC50 values between genotypes with the exception of cytisine. Cytisine was more potent in 5 (+/+) as compared to 5 (–/–) mice (EC50: 5 (+/+), 9.27 ± 0.18 μM; 5 (–/–), 14.95 ± 0.47 μM; P < 0.01). F, maximum calcium signal for each agonist at somatic nAChRs obtained by fitting the dose–response to eqn (2) without prior normalization. Open columns are results from 5 (+/+) mice, hatched columns are the surplus of responses as seen in 5 (–/–) animals. All agonists show a tendency towards higher efficacy in the 5 (–/–) responses, although the difference is only significant for DMPP (344 ± 11 nMversus 443 ± 17 nM; n = 20 and 24 for 5 (+/+) and 5 (–/–) mice, respectively; P < 0.01), epibatidine (499 ± 24 nMversus 599 ± 28 nM; n = 20 for both 5 (+/+) and 5 (–/–); P < 0.05) and cytisine (370 ± 17 nMversus 438 ± 23 nM; n = 26 and 30 for 5 (+/+) and 5 (–/–); P < 0.05). Maximal effects of ACh in 5 (+/+) animals (530 ± 29 nM; n = 20) were significantly larger than effects of DMPP (P < 0.01), cytisine (P < 0.01), and nicotine (P < 0.05). In 5 (–/–) animals, the maximal effects of ACh (551 ± 27 nM; n = 22) significantly exceeded those of DMPP and cytisine (P < 0.01).
, 百拇医药
A–E, transmitter release overflow was evaluated in preparations at 4–6 DIV that were preloaded with [3H]NA as described in Methods. Responses in the presence of 0.25 μM TTX to DMPP (A), cytisine (B), nicotine (C), ACh (in the presence of 0.1 μM atropine, D) and epibatidine (E) are shown. Data points show the number of counts min–1 of [3H]NA normalized with respect to the maximum effect for each agonist in a particular experiment (DMPP, 66–100 μM; nicotine, 60–120 μM; cytisine, 75–166 μM; Ach, 150–600 μM; epibatidine, 66–100 nM) and are the averaged values from three individual cultures. Note that beyond these maximum concentrations, the effect of agonists decline again. Curves show the results of fitting eqn (2) to data points with the constraint that the maximum response was set to 1.0. Data points of supramaximal agonist concentrations were excluded from the fits. Fit parameters for EC50 values and the slope factors are shown in Table 2. The symbols used to depict results for 5 (+/+) and 5 (–/–) animals, respectively, are indicated in each panel. F, the maximal NA release was calculated by averaging all maximal effects an agonist had in individual cultures of either the 5 (+/+) or the 5 (–/–) genotype. Data are means ± S.E.M.; n = 9 (DMPP at 5 (+/+)) to 27 (cytisine and ACh at 5 (–/–)) individual cultures. Open columns are results from 5 (+/+) mice, hatched columns are the surplus of responses as seen in 5 (–/–) animals. Note the striking difference of the maximal release which is independent of the type of agonist (P < 0.01). The overall maximal NA outflow (pooled data from all five agonists) was 2.67-fold larger in 5 (–/–) than in 5 (+/+) animals (5 (+/+), 6.82 ± 0.49%, n = 65; 5 (–/–), 18.23 ± 0.42%, n = 112; P < 0.01). Maximal effects of ACh in 5 (+/+) animals (7.63 ± 1.28 %; n = 15 individual cultures) did not significantly differ from the maximal effects of the other agonists (P > 0.05). Maximal effects of ACh in 5 (–/–) animals (18.39 ± 1.01 %; n = 27 individual cultures) did not significantly differ from the maximal effects of the other agonists (P > 0.05).
, 百拇医药
With one notable exception, cytisine, the EC50 values for the activation of somatic receptors were not substantially different in 5 (+/+) and 5 (–/–) mice (Fig. 1; Table 1). Cytisine was about 1.6 times less potent in the 5 (–/–) mice compared with 5 (+/+) controls (Fig. 1; Tables 1, P < 0.01). This shift of potency was sufficiently large to change the rank order of agonist potency in the 5 (–/–) animals to DMPP (1.50), followed by cytisine (1.0), nicotine (1.00) and ACh (0.42).
, 百拇医药
In addition to the significant effects on rank order of agonist potency, there was a trend towards increased efficacy of a subset of the nicotinic agonists, as assessed from the magnitude of the somatic responses in 5 (–/–) versus 5 (+/+)-derived neurones (Fig. 1F). Thus, the maximum increases in calcium measured in 5 (–/–) animals were significantly larger in response to cytisine (P < 0.05), DMPP (P < 0.01) and epibatidine (P < 0.05) but did not differ significantly for nicotine and ACh (Fig. 1F). The trend towards a higher maximum responses was also apparent in analyses of data pooled for all agonists (Fig. 1F, overall). Hence, in 5 (–/–) mice, the maximum increase of calcium in response to the agonists exceeded the effects in 5 (+/+) mice by a factor of 1.14 (P < 0.01, n = 113 and 123 for 5 (+/+) and 5 (–/–) mice, respectively).
, 百拇医药
Somatic nAChRs: assessment of function by low concentration potency ratios confirms results of full concentration–response curves
Estimates of EC50 values when deduced from full concentration–response curves may be misleading (Covernton et al. 1994; Kristufek et al. 1999). Therefore, we used an additional approach to compare the potencies of our four standard agonists at concentrations not exceeding EC50 values (‘low-concentration potency ratios’, see Covernton et al. 1994). This approach minimizes the contribution of receptor desensitization seen at high concentration of agonists and eliminates ‘between neurone’ variance as comparative measurements of potency ratios can be done on the same cells (Figs 2 and 3). Potency ratios determined from individual neurones could then be pooled for calculation of the statistics (Fig. 4).
, 百拇医药
Examples are shown from one of the three 5 (–/–) neurones successfully assayed with both calcium imaging and whole cell current recording to assess the effects of agonist at the low end of the concentration–response curve. A, calcium transients, concurrently determined with whole-cell currents, in response to 12-s applications (indicated by bars) of nicotine, cytisine, DMPP or ACh (in the presence of 0.1 μM atropine). Concentrations were 3, 5 and 10 μM (nicotine, cytisine and DMPP, respectively), and 5 and 10 μM (ACh). Sharp deviations in current traces are due to the CCD camera shutter. The experiment was conducted on a 4 DIV preparation. B, dose–response relationship of peak calcium transients constructed from original recordings as shown in A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine (Cyt); dashed lines and open symbols are effects of DMPP (), nicotine (Nic, ) and ACh (). Potency ratios relative to cytisine (1.0) were 1.21 (DMPP), 0.74 (nicotine) and 0.37 (ACh). C, dose–response relationship of peak currents constructed from original recordings as shown in A. Data are mean peak transients measured in duplicate for each agonist. Curves based on eqn (2) were simultaneously fitted to data points by unweighted non-linear regression using the Allfit routine with the constraint of a shared slope and a fixed maximum as described in Methods. Filled inverted triangles and continuous line show the concentration–response curve for cytisine; dashed lines and open symbols are effects of DMPP (), nicotine () and ACh (). Potency ratios relative to cytisine (1.0) were 1.49 (DMPP), 0.88 (nicotine) and 0.49 (ACh).
, http://www.100md.com
A, low-dose potency ratios were determined in individual cells from 5 (+/+) mice at the indicated age of cultures and as shown in Fig. 2 for a cell after 4 DIV. Data points are mean potency ratios ± S.E.M. (relative to the standard, cytisine) of 6 (1 DIV), 12 (2 DIV), 21 (4 DIV), 7 (6 DIV), 2 (9 DIV) and 6 (12 DIV) neurones. Filled inverted triangles and continuous line show the potency ratio for cytisine, set to unity; dashed lines and open symbols are the ratios of DMPP (), nicotine () and ACh (in the presence of 0.1 μM atropine, ). Note the significant change of potency ratios, particularly for DMPP, between 1 and 6 DIV (P < 0.01). At 1 DIV, the DMPP to cytisine ratio was 0.30 ± 0.02 (n = 6; significantly different from 1: P < 0.01), from where it increased up to 0.95 ± 0.01 (n = 7) after 6 DIV. B, results obtained from 5 (–/–) mice by the protocol described in A; symbols identical to A. Data points are mean potency ratios ± S.E.M. (relative to the standard, cytisine) of 6 (1 DIV), 16 (4 DIV), 8 (6 DIV), 14 (7 DIV) and 8 (12 DIV) neurones. Note that regardless of the age of cultures, DMPP was consistently more potent than cytisine. At 1 DIV, the DMPP to cytisine ratio was 1.39 ± 0.01 (n = 6; significantly different from 1: P < 0.01). At 7 DIV, the DMPP to cytisine ratio was 1.37 ± 0.02 (n = 14).
, 百拇医药
Potency ratios determined at lower agonist doses confirmed our findings on the differences in rank order potency and potency ratios of neurones from 5 (+/+) versus 5 (–/–) mice, as deduced from the EC50 values. Hence, in SCG neurones of 5 (+/+) mice, cytisine was the most potent agonist, followed by DMPP and nicotine, and then ACh (1, 0.67 ± 0.02, 0.68 ± 0.03 and 0.51 ± 0.02, respectively; means ± S.E.M., n = 21 from four different preparations; see Fig. 4A, data points at 4 DIV). In contrast, examination of SCG neurones from 5 (–/–) mice revealed the distinct rank order potency of DMPP > cytisine > nicotine > > ACh. Thus direct assessment of low-concentration potency ratios (cytisine, 1; DMPP, 1.34 ± 0.02; nicotine, 0.90 ± 0.01; Ach, 0.30 ± 0.01; means ± S.E.M., n = 16 out of three different preparations; see Fig. 4B, data points at 4 DIV) confirms the results obtained from full dose–response curves.
, 百拇医药
Simultaneous fura-2 calcium imaging and patch-clamp recordings in the same cell further confirmed the differences of somatic nAChRs agonist potency ratios between 5 (+/+) and 5 (–/–) mice. Both techniques yielded identical potency ratios in within genotype comparisons of either 5 (+/+) or 5 (–/–) mice (compare Figs 2 and 3). It is notable that the time course of calcium transients was much slower than the evoked currents recorded in response to application of agonists. In addition we noted a trend towards higher magnitude changes in DMPP-evoked Ca2+ signalling in neurones from 5 subunit-deleted mice (compare Figs 2 and 3).
, 百拇医药
Potency ratios are affected by the age of cultures in 5 (+/+) mice, but not in 5 (–/–) mice
All observations presented so far were made on mouse SCG neurones maintained in culture for 4–5 days. However, the subunit composition of nAChRs changes with the age of cultures (De Koninck & Cooper, 1995). We therefore wanted to know whether these changes were paralleled by an adjustment of potency ratios. It is striking that cytisine has an exceedingly high potency compared to the other agonists when tested after 1 DIV in SCG neurones from 5 (+/+) mice (potency ratio of DMPP compared to cytisine, 0.30 ± 0.02, means ± S.E.M.; n = 6 of two preparations, Fig. 4A). By 4 DIV, the ratio declined to 0.67 ± 0.02 (n = 21 of four preparations, see above), and after 6 DIV, DMPP and cytisine were almost equipotent in neurones from 5 (+/+) mice (cytisine, 1; DMPP, 0.95 ± 0.01, n = 7 of two preparations; difference to 1 DIV significant at P < 0.01). The changes in the potency of nicotine and ACh initially followed the time course of DMPP, but then declined relative to DMPP after 9 and 12 DIV (Fig. 4A).
, http://www.100md.com
In contrast to the developmental changes in somatic responses in 5 (+/+) animals, somatic nAChRs of 5 (–/–) mice remained about constant throughout the incubation period. DMPP was more potent than cytisine at all points examined (potency ratio after 1 DIV, 1.39 ± 0.01; n = 6 of two preparations, Fig. 4B). Hence, the 5 genotypes were most distinct at 1 DIV, when potency ratios between DMPP and cytisine differed by the quotient 1.39/0.30 (i.e. 4.63). Overall, these data are consistent with changes in the nAChR composition with in vitro development of 5 (+/+) neurones that does not occur when the 5 subunit is absent.
, 百拇医药
TTX-sensitive versus TTX-insensitive transmitter release
Experiments delineated above assess the pharmacological fingerprints of somatic nAChRs in SCG neurones from both 5 (+/+) and 5 (–/–) mice. Our next task was to apply a similar analysis to determine the functional profile of the presynaptic receptor pools. As detailed in a previous study (Kristufek et al. 1999), the function of prejunctional receptors was monitored indirectly by measuring the outflow of preloaded [3H]NA in response to nicotinic agonists. The component of transmitter outflow that remains upon stimulation with nicotine in the presence of TTX (‘TTX-insensitive transmitter release’) thus reflects the function of presynaptic receptors (Kristufek et al. 1999). Subtraction of this component from overall release (i.e. in the absence of TTX) reveals the ‘TTX-sensitive component’.
, http://www.100md.com
We first examined whether SCG neurones from mice, like those from rat, have both the TTX-sensitive as well as the TTX-insensitive component. Results from these experiments for both 5 (+/+) and 5 (–/–) animals are shown in Fig. 5. Curve fits of data points by eqn (2) yielded identical EC50 values for the TTX-insensitive component of nicotine-induced transmitter outflow in 5 (+/+) and 5 (–/–) mice (5 (+/+), 37.46 μM; 5 (–/–), 37.04 μM, Fig. 5). Note, however, that the maximum of the TTX-insensitive component was strikingly different between 5 (–/–) and 5 (+/+) mice. As shown in more detail below (Fig. 7), TTX-insensitive transmitter release was significantly enhanced in 5 (–/–) mice not only in response to nicotine, but also by the other agonists tested.
, 百拇医药
A1, exploring full concentration–response curves in 5 (+/+) mice. Nicotine-induced transmitter release from 5 DIV SCG cultures under control conditions (overall release, ) and in the presence of 0.25 μM TTX (TTX-insensitive release, ). Data are means ± S.E.M., n = 3 individual culture discs. Data points indicated by circles (TTX-sensitive release) were obtained by subtracting mean values of nicotine-induced release in the presence of TTX () from overall release (). A2, curve fits of TTX-sensitive () and TTX-insensitive () nicotine-induced transmitter release by applying eqn (2) yielded the following parameters: EC50 TTX-sensitive, 15.82 ± 2.52 μM; EC50 TTX-insensitive, 37.46 ± 0.98 μM; maximal effect TTX-sensitive, 2.81 ± 0.22%; maximal effect TTX-insensitive, 3.47 ± 0.06%; slope factor p for TTX-sensitive, 2.03 ± 0.48; slope factor p for TTX-insensitive, 4.82 ± 0.42. Data points for the curve fits were taken from A1. A3, exploring the low concentration end of the dose–response curve. Nicotine-induced transmitter release from 2 DIV SCG cultures of 5 (+/+) mice under control conditions (overall release, ) and in the presence of 0.25 μM TTX (TTX-insensitive release, ). Means ± S.E.M., n = 3 release experiments. Each data point was calculated from three triplets of individual culture discs. The data points indicated by circles (TTX-sensitive release) were obtained by subtracting mean values of nicotine-induced release in the presence of TTX () from overall release (). Note that TTX-sensitive release reached a near maximal value of 5.52 ± 0.31% (n = 3 cultures in triplicate) at 30 μM nicotine. B1 and B2, same experimental protocols as shown in A1 and A2, except that transmitter release was determined in 4 DIV cultures obtained from 5 (–/–) mice. Fitting curves by eqn (2) to the data points shown in B1 yielded the following parameters: EC50 TTX-sensitive, 11.71 ± 2.13 μM; EC50 TTX-insensitive, 37.04 ± 0.56 μM; maximal effect TTX-sensitive, 5.23 ± 0.63%; maximal effect TTX-insensitive, 15.58 ± 0.18%; slope factor p for TTX-sensitive, 2.59 ± 1.01; slope factor p for TTX-insensitive, 3.58 ± 0.15. Note that in comparison with 5 (+/+) mice, the two preparations differ grossly in their maximal values of the TTX-insensitive component. B3, same experimental protocols as shown in A3, except that transmitter release was determined in 2 DIV cultures obtained from 5 (–/–) mice. Note that TTX-sensitive release reached a maximum of 5.79 ± 0.19% (n = 3 cultures in triplicate) in response to only 10 μM nicotine (versus 30 μM in 5 (+/+) mice).
, http://www.100md.com
TTX-sensitive release was induced with an EC50 of 15.82 μM in 5 (+/+) and an EC50 of 11.71 μM in 5 (–/–) mice (Fig. 5A2 and B2) and thus appeared to be more potently activated in animals lacking the 5 subunit. A plausible explanation for the higher potency of nicotine in inducing TTX-sensitive release in 5 (–/–) mice might be a higher efficacy of the agonists on nAChRs assembled without the contribution of 5 subunits. If this were the case, and assuming that neither the properties or distribution of voltage-gated sodium channels are affected by the 5 subunit genotype, a lower concentration of nicotine might suffice to depolarize neurones to the threshold level for the activation of sodium channels. We tested this hypothesis by exploring transmitter release upon exposure of cultures to low concentrations of nicotine in the presence and absence of TTX (Fig. 5A3 and B3). Our experiments revealed that the TTX-sensitive component reached about the same maximum in both 5 (+/+) and 5 (–/–) mice. However, maximal effects were obtained with 10 μM nicotine in 5 (–/–) animals, whereas it took about 30 μM of nicotine in 5 (+/+) mice (Fig. 5A3 and B3).
, 百拇医药
These observations are compatible with the idea that nAChRs assembled in 5 (–/–) mice are activated more efficaciously by nicotine than those in 5 (+/+) controls. Note that release measured in all cases is entirely dependent on the presence of calcium in the superfusion buffer even in 5 (–/–) animals, where the TTX-insensitive component of nicotine-induced transmitter release is markedly enhanced relative to control (Fig. 6). On average, 100 μM nicotine causes a 22.8 ± 4.1% (n = 24) depletion of radioactivity in cultures after 2 DIV (see Fig. 9).
, 百拇医药
Basal transmitter release and the release induced by 100 μM nicotine (15 s, indicated by arrows) in the presence of 0.25 μM TTX. Control buffer containing 2 mM Ca2+ (cultures 3 DIV, ); superfusion buffer with and without (indicated by horizontal bar) 2 mM Ca2+ (cultures 2 DIV, ). Data points are means ± S.E.M., n = 3.
A, somatic receptors: SCG cultures from either 5 (+/+) or 5 (–/–) mice were maintained for 1 DIV (open columns), 4/5 DIV (filled columns), or 7 DIV (hatched columns). Maximal effects of nicotine were determined by fitting eqn (2) to calcium transients in response to a full range of nicotine concentrations as shown in Fig. 1F. Note that nicotine exerted highest effects at 4/5 DIV both in 5 (+/+) and 5 (–/–) mice. In 5 (+/+) mice, values at 4/5 DIV were significantly larger than at 1 DIV (P < 0.05) or 7 DIV (P < 0.01). In 5 (–/–) mice, values at 4/5 DIV significantly exceed those at 7 DIV (P < 0.05). Maximal effects of nicotine were significantly larger in 5 (–/–) than in 5 (+/+) mice at 1 DIV and 7 DIV (P < 0.01). Data are means ± S.E.M., n = 9–27 individual cells. B, prejunctional receptors: transmitter release in response to 100 μM nicotine in the presence of 0.25 μM TTX. SCG cultures from either 5 (+/+) or 5 (–/–) mice were maintained for 2 DIV (open columns), 5 DIV (filled columns), or 8 DIV (hatched columns). Data are means ± S.E.M., n = 24 individual cultures (at 2 DIV), 12 (at 5 DIV) and 9 (at 8 DIV). Note that in the presence of TTX, 100 μM nicotine will cause maximal transmitter release (see Figs 5 and 7), and that at all ages, cultures obtained from 5 (–/–) mice showed significantly more agonist-induced NA release than 5 (+/+) animals. NA release in response to nicotine significantly declined between 5 DIV and 8 DIV both in 5 (+/+) and 5 (–/–) animals (P < 0.01), and between 2 DIV and 5 DIV in cultures taken from 5 (–/–) mice (P < 0.01).
, 百拇医药
Prejunctional nAChRs: assessment of function by full concentration–response curves of nicotinic agonists in 5 (+/+) and 5 (–/–) mice
Having assessed the basic properties of TTX-sensitive and TTX-insensitive transmitter release in both 5 (+/+) and 5 (–/–) mice we next examined the pharmacological profile of the prejunctional nAChRs in the 5 (+/+) and 5 (–/–) animals in more detail. EC50 values deduced from full concentration–response curves indicate a lower potency of DMPP and ACh, but not of nicotine or cytisine, in 5 (+/+) mice (Fig. 7; Table 2) as compared to the rat SCG (Kristufek et al. 1999). Potency ratios calculated from EC50 values relative to cytisine (1.0) in 5 (+/+) mice were: DMPP, 1.61; nicotine, 1.64; Ach, 0.28. In Sprague-Dawley rats, ratios were: DMPP, 2.17; nicotine, 1.41; and Ach, 0.43 (data in rats taken from Kristufek et al. 1999).
, 百拇医药
Deletion of the 5 subunit as evaluated from the transmitter release assay shifted the EC50 values of all agonists except of cytisine towards a higher potency (Fig. 7; Table 2). Nevertheless, potency ratios in 5 (+/+) controls closely resembled the values of 5 (–/–) animals (cytisine, 1; DMPP, 1.84; nicotine, 1.59; Ach, 0.47).
However, the most conspicuous effect of the deletion of the 5 subunit was the impact it had on the efficacy of nicotinic agonists: all agonists tested stimulated a higher level of release at significantly lower doses in 5 (–/–) compared with 5 (+/+) animals (Fig. 7F). Transmitter release upon activation of prejunctional receptors was enhanced by nearly 3-fold (Fig. 7F).
, 百拇医药
Prejunctional nAChRs: assessment of function by low-concentration potency ratios confirms results from full concentration–response curves
Analogous to our assessment of the function of somatic nAChRs mentioned above we sought confirmation of the potency ratios calculated from EC50 values by applying the two most discriminating agonists, cytisine and DMPP, at low concentrations (Fig. 8). After 5 DIV, DMPP was 2.12 ± 0.16 (n = 3 release experiments) and 2.00 ± 0.11 (n = 3 release experiments) times more potent than cytisine in the 5 (+/+) and 5 (–/–) animals, respectively (Fig. 8). In cultures examined between 2 DIV and 8 DIV, DMPP was consistently more potent than cytisine in both 5 (+/+) and 5 (–/–) animals (Fig. 8B1 and B2).
, 百拇医药
Age-dependent properties of SCG cultures: impact of the time in vitro on agonist efficacies
As mentioned above, the age of cultures had a significant impact on the relative potency of nicotinic agonists at somatic receptors in 5 (+/+) mice (Fig. 4). However, the age of cultures also affected the overall efficacy of nicotine. Hence, in both 5 (+/+) and 5 (–/–) animals, the increase of intracellular calcium obtained by nicotine reached a maximum at 4 DIV and declined markedly after 7 DIV (Fig. 9A).
, 百拇医药
The time course of the changes in efficacy of nicotine at prejunctional receptors was determined by measuring transmitter outflow in response to a standard concentration of 100 μM nicotine (in the presence of TTX) at several different DIV and for both the 5 (+/+) and 5 (–/–) genotypes (2, 5, and 8 DIV; Fig. 9B). As noted for somatic receptors, the efficacy of nicotine significantly declined between 5 and 8 DIV in both genotypes, and between 2 and 5 DIV in 5 (–/–) mice. The waning of the effect of nicotine between 5 and 8 DIV was not due to a general loss in the release capacity of cultures, as transmitter outflow in response to electrical field stimulation did not differ significantly either in 5 (+/+) or in 5 (–/–) mice between 5 and 8 DIV (P > 0.05; data not shown).
, http://www.100md.com
Prejunctional nAChRs: assessment of the efficacy of nicotine in the atrium preparation of 5 (+/+) and 5 (–/–) mice
We corroborated the increased efficacy of prejunctional nicotinic receptors in an acute atrium preparation taken from 6-day-old animals (Fig. 10). Transmitter release induced by a concentration of nicotine that we know caused maximal effect under conditions of action potential blockade (Figs 5 and 7) was significantly larger in 5 (–/–) compared to 5 (+/+) mice (Fig. 10). In contrast, transmitter release in response to electrical field stimulation was not affected by the genotype (Fig. 10).
, 百拇医药
Transmitter release overflow was evaluated in acute atrium preparations from 6-day-old animals upon preloading with [3H]NA as described in Methods. The figure shows basal overflow, overflow induced by electrical field stimulation (120 pulses, 3 Hz), and the overflow in response to 100 μM nicotine in the presence of 0.5 μM TTX. Data points are the mean overflow ± S.E.M. from nine (wild-type) or 12 (knockout) atria. Transmitter overflow induced by nicotine was significantly larger in 5 (–/–) compared to 5 (+/+) animals (P < 0.01). Basal and electrically induced overflow did not differ significantly between preparations obtained from either knockout or wild-type animals (P > 0.05).
, 百拇医药
Discussion
Prior studies demonstrate distinct pharmacological properties of somatic–dendritic versus axonally targeted nAChRs of rat SCG neurones in vitro (Kristufek et al. 1999). The current study extends these observations by initiating a systematic analysis of the potential role of nAChR subunit composition in distinct receptor pools, using mice with targeted deletions of individual nAChR subunits (for reviews see Wang et al. 2002b; Champtiaux & Changeux, 2004; Dajas-Bailador & Wonnacott, 2004). In particular, this study explores the role of 5 subunits, testing whether pharmacological differences between somato-dendritic versus presynaptic nAChRs may be due, at least in part, to the distinct role of the 5 subunit in nAChRs in different neuronal domains.
, 百拇医药
The simplest summary of these combined genetic and pharmacological analyses is that 5 nAChR subunits differentially contribute to nAChR pools in different cellular locales. The most intriguing and unexpected finding from our results is the enhancement of presynaptic nAChR-mediated NA release consequent to the deletion of 5 subunits from axonally targeted nAChRs. The implications of these findings are discussed below.
Overall, we provide three new observations regarding the profile of nAChRs expressed by mouse SCG neurones in general and the contributions of the 5 nAChR subunit in particular: (1) the pharmacological profile of somatic nAChRs depends on developmental age and on the presence or absence of 5 subunit gene expression; (2) the pharmacological profile of presynaptic nAChRs differs from that of the somatic nAChRs by being independent of developmental age and of 5 subunit gene expression; and (3) the effects of 5 deletion are most evident in changes of presynaptic nAChRs, implicating 5 subunits in constraining the number and/or efficacy of nAChRs linked to the presynaptic facilitation of NA release. Complementary studies in more intact (acute atrium) preparations confirm the hypothesized role of 5 subunits in shaping nicotine-evoked NA release (Fig. 10).
, 百拇医药
Contribution of 5 subunits to somatic nAChRs
Our studies revealed both age- and 5 expression-dependent differences in somatic nAChRs, including significantly higher potency of cytisine compared to DMPP at early stages (1 DIV after removal of ganglia from P4/5 mice), whereas DMPP and cytisine were essentially equipotent after 1 week in vitro. In contrast, in mice lacking the 5-nAChR subunit, somatic nAChRs were described by a rank order potency of DMPP > cytisine irrespective of the age of cultures. These and other data (discussed below, and see McNerney et al. 2000; Skok, 2002; Vincler & Eisenach, 2003; Nai et al. 2003) are consistent with our suggestion that mature somatic nAChRs in mouse SCG include 354* nAChRs as well as 3542* nAChRs.
, 百拇医药
The rat SCG contains mRNA for 3, 5, 7, 2 and 4 (Mandelzys et al. 1995; De Koninck & Cooper, 1995; Zhou et al. 1998; D. Kristufek and S. Huck, unpublished observation). If we assume an identical subunit profile in the mouse, and if we further assume that the deletion of one subunit is not compensated by the appearance or up-regulation of another (see Kedmi et al. 2004), we should be able to assess the contribution of 5 to somatic nAChRs based on the differences in pharmacological profile per se. Elegant studies, using nAChR subunit-specific antibodies, have provided both immunohistochemical and immunoprecipitation-based evidence for the probable composition of peripheral neurone-type nAChRs in chick and human (Conroy & Berg, 1995; Wang et al. 1996; Gerzanich et al. 1998). Although comparable studies have yet to be done in rat or mouse, the prior work on other species, together with data from heterologous expression of known subunit combinations, provide important guidelines for the current study.
, 百拇医药
In the chick ciliary ganglion, most of the 5 gene product in fully assembled receptors is associated with both 3 and 4 subunits. About 20% of these receptors also contain 2 (Conroy & Berg, 1995). The first studies of 5 in heterologous recombination with other and subunits examined 5 plus 4 and 2 subunits from chick (Ramirez-Latorre et al. 1996). The 542* nAChRs had a higher conductance and a faster rate of agonist-induced desensitization than nAChRs formed without 5. Co-transfection of chick 5 with 34 in (human) BOSC 23 cells added an additional, low affinity component (EC50, 512 μM) of ACh-induced currents to the higher-affinity profile (EC50, 66 μM) seen with simple pairwise expression of 3 and 4 (Fucile et al. 1997). These data, and our observations, are in keeping with findings in the chick SCG that functional deletion of the 5 subunit by antisense oligonucleotide treatment removes nAChRs with relatively low affinity to ACh and cytisine (Yu & Role, 1998b). However, cotransfection of chick 5 with 34 in Xenopus oocytes, or of chick 5 with 32 in BOSC 23 cells, had little effect on either the potency or the efficacy of ACh (Fucile et al. 1997).
, 百拇医药
In the human neuroblastoma SH-SY5Y cell line, both 3 and 5 could be copurified by the 2-specific antibody mAb290, implying co-assembly of these three subunits into complexes (Wang et al. 1996). About 50% of 3 receptors also contained 2 (Wang et al. 1996; Gerzanich et al. 1998). Indirect evidence suggests that 4 might substitute for 2 in the remaining receptors (Gerzanich et al. 1998). It is clearly pertinent to interpretation of the current study to consider how the presence of the 5 subunit modifies combinations of 34, 32 and possibly 324 human receptor subunits. This question has been addressed by co-expression of various combinations of cloned human 3, 2, 4 and 5 receptors in Xenopus oocytes (Wang et al. 1996; Gerzanich et al. 1998).
, 百拇医药
The presence of 5 subunits increased both the rate of desensitization and the calcium permeability of receptors containing 32 or 34 (Gerzanich et al. 1998). Agonist efficacies relative to ACh were both enhanced and reduced (e.g. for nicotine or cytisine, respectively, at receptors containing 32). Moreover, the presence of 5 dramatically enhanced the potency of agonists at receptors including 32, and to a lesser extent at 34 containing receptors. Expression of all four subunits 3, 2, 4 and 5 resulted in complex concentration–response relations for ACh and DMPP that were fitted with the sum of two Hill equations (Gerzanich et al. 1998).
, http://www.100md.com
Overall these studies, like ours, indicate that the inclusion of 5 subunit in nAChR complexes may selectively affect the potency and efficacy of nicotinic agonists. Depending on the age of the preparation, cytisine was either more potent than, or equipotent to, DMPP in activation of somatic receptors in wild-type (WT) mice. The deletion of 5 reversed the potency ratios so that DMPP exceeded cytisine. The simplest interpretation of the changes we observe in somatic nAChRs with and without 5 deletion is that 5 is a more prominent contributor to shaping the profile of nAChRs in more mature neurones.
, http://www.100md.com
The differences in the agonist potency and efficacy at somatic nAChRs with/without 5 subunits reported here, are more subtle than those seen by adding 5 to pairwise subunit combinations of 32 or 34 (or even 42) expressed in oocytes (Ramirez-Latorre et al. 1996; Gerzanich et al. 1998). This may be due to species differences (McGehee & Role, 1995), the choice of the system used to express cloned receptors (Fucile et al. 1997) or additional nAChR subunits that might modify the overt impact of 5. Of particular note are the many studies suggesting that native (somatic) nAChRs are not accurately recapitulated by combinations of two or three known subunits in heterologous expression systems (Covernton et al. 1994; Silvilotti et al. 1997; Lewis et al. 1997).
, 百拇医药
Contribution of 5 subunits to prejunctional/preterminal nAChRs
In contrast to the apparent fine-tuning of the profile of somatic nAChRs, the current study unveiled dramatic effects of 5 expression (or lack thereof) on the extent of nAChR-activated (TTX-resistant) transmitter release. Such findings must be related to the plethora of prior work implicating 5 in modulating the number, profile, rate of desensitization and calcium permeability of comparable pairwise nAChR subunit combinations (delineated above).
, http://www.100md.com
Indeed, measurements of somatic calcium fluxes in the 5 (–/–) revealed slight increases compared with assays in WT mice. One might reason that even such a modest increase may be enough to support a dramatic increase in prejunctional nAChR-mediated NA release as exocytosis can follow calcium concentration to up to the fourth power (Regehr & Stevens, 2001). However, this explanation seems unlikely for three reasons. First, all nAChR agonists were much more effective in stimulating TTX-resistant NA release in 5 (–/–) versus 5 (+/+) animals (i.e. the increased efficacy in activation of prejunctional receptors in 5 (–/–) mice was seen with ACh as well as other agonists). In contrast, the changes in Ca2+ flux at somatic receptors in 5 (+/+) and 5 (–/–) animals were agonist-dependent (e.g. ACh efficacy did not change). Second, even a fourth-power function of the overall increase of the somatic calcium signal (1.144 = 1.69) hardly reaches the magnitude of the observed increase in release detected in the 5 (–/–) mice (2.7-fold greater than 5 (+/+)). Last but not least, our findings vis-à-vis nicotine-induced changes in Ca2+ signals in 5 (+/+) versus 5 (–/–) mice appear to run contrary to predictions derived from prior studies. Thus earlier work had indicated that the exclusion of 5 would be expected to yield nAChRs of lower Ca2+ permeability (Gerzanich et al. 1998), whereas we find that genetic removal of 5 subunit results in the assembly of prejunctional receptors that were nearly 3-fold more efficacious in stimulating Ca2+-dependent NA release.
, 百拇医药
We propose two possible mechanisms to explain how altering the expression of 5 nAChR subunits might regulate the extent of prejunctional nAChR-mediated NA release from sympathetic neurones: (1) 5-containing nAChRs, although somewhat higher in Ca2+ permeability, are less efficiently coupled to calcium-induced calcium release (CICR) from internal stores and thus less efficacious in stimulation NA release; and (2) the synthesis and incorporation of 5 into nAChRs decreases the assembly and/or insertion of non-5-containing nAChR complexes, thus decreasing the overall number of functional nAChRs within the axon terminal domain. Arguments pertinent to these models are discussed below.
, http://www.100md.com
Coupling of 5 (+/+) versus 5 (–/–) prejunctional nAChRs to CICR and NA release
Several recent studies have emphasized the contribution of CICR to the mechanism(s) underlying the coupling of activation of presynaptic nAChRs to increased exocytosis (e.g. Shoop et al. 2001; Brain et al. 2001; Dajas-Bailador et al. 2002; Girod et al. 2003; Sharma & Vijayaraghavan, 2003; for review see Dajas-Bailador & Wonnacott, 2004). Accordingly, CICRs appear to play an important role in more sustained aspects (many minutes) of nicotine-evoked changes in Ca2+ signalling (for review see Dajas-Bailador & Wonnacott, 2004). As 5-containing receptors have greater rates and amounts of desensitization (e.g. Ramirez-Latorre et al. 1996; Gerzanich et al. 1998), nAChRs that do not include the 5 subunit might be more effectively coupled to enhanced release due to differences in the time course and extent of changes in local Ca2+ influx, and hence in CICR activation. Thus a more transient increase Ca2+ influx might be less effective in stimulating CICR, even if the surge in local Ca2+ concentration were greater in magnitude (e.g. Shoop et al. 2001; Brain et al. 2001; Dajas-Bailador et al. 2002; Girod et al. 2003; Sharma & Vijayaraghavan, 2003; for review see Dajas-Bailador & Wonnacott, 2004). However, it is not clear whether such a mechanism, though feasible, would be sufficiently different in coupling to CICR to explain the remarkable enhancement of transmitter release seen in the 5 (–/–) animals.
, 百拇医药
Role of 5 subunit gene expression in regulating the number of prejunctional nAChRs
Several investigators have underscored the effects of 5 co-expression on the overall number of functional surface nAChRs. Thus, BOSC 23 cells transfected with 34 show a reduction in the number of nicotine-responsive cells and of the maximum inducible current upon cotransfection with 5 (Fucile et al. 1997). Likewise, the number of membrane-incorporated 32 receptors detected by [125I]mAb210 is about halved if cotransfected with 5 in Xenopus oocytes (Wang et al. 1996). According to this view the presence or absence of the 5 subunit may affect the number nAChRs on the cell surface, rather than influencing the properties of individual receptors.
, http://www.100md.com
One mechanism whereby increased expression of 5 subunits might be expected to decrease the number of surface nAChRs is suggested by sucrose gradient centrifugation and Western blot analysis by (Wang et al. 1996). These investigators suggest that the formation of 325 (and possibly 345*) nAChRs, may first require the interaction of 2 with 5 prior to the co-assembly with 3 (Wang et al. 1996). This process may affect the kinetics of the assembly and/or the membrane incorporation of 5-containing nAChRs. This hypothesis, like the CICR coupling concept presented above would require that somatic and prejunctional receptors are differentially affected by the expression of 5 in order to account for the observations in the present study.
, http://www.100md.com
In conclusion, our experiments show that deletion of the 5-nAChR subunit differentially affects somatic and prejunctional nAChRs in mouse SCG neurones. An important role of 5 subunits in determining the efficacy of nAChRs that facilitate action potential independent NA release is demonstrated. Despite these insights, we are not yet able to accurately predict the subunit composition of the nAChRs at the two different sites. However, ongoing experiments with mice lacking additional subunits, combined applications of the RNAi technique for deletion of selected subunits and immunolocalization studies with subunit-specific antibodies should soon permit identification of the and subunits that assemble into somatic and prejunctional receptors, respectively.
, 百拇医药
References
Boehm S & Huck S (1995). 2-Adrenoreceptor-mediated inhibition of acetylcholine-induced noradrenaline release from rat sympathetic neurons: an action at voltage-gated Ca2+ channels. Neuroscience 69, 221–231.
Brain KL, Trout SJ, Jackson VM, Dass N & Cunnane DC (2001). Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores. Neuroscience 106, 395–403.
, 百拇医药
Champtiaux N & Changeux J-P (2004). Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog Brain Res 145, 235–251.
Conroy WG & Berg DK (1995). Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J Biol Chem 270, 4424–4431.
Conroy WG, Liu Z, Nai Q, Coggan JS & Berg DK (2003). PDZ-containing proteins provide a functional postsynaptic scaffold for nicotinic receptors in neurons. Neuron 38, 759–771.
, http://www.100md.com
Conroy WG, Ogden LF & Berg DK (2000). Cluster formation of 7-containing nicotinic receptors at interneuronal interfaces in cell culture. Neuropharmacology 39, 2699–2705.
Covernton PJO, Kojima H, Silvilotti LG, Gibb AJ & Colquhoun D (1994). Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J Physiol 481, 27–34.
Cuevas J, Roth AL & Berg DK (2000). Two distinct classes of functional 7-containing nicotinic receptor on rat superior cervical ganglion neurons. J Physiol 525, 735–746.
, http://www.100md.com
Dajas-Bailador FA, Mogg AJ & Wonnacott S (2002). Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores. J Neurochem 81, 606–614.
Dajas-Bailador FA & Wonnacott S (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25, 317–324.
De Koninck P & Cooper E (1995). Differential regulation of neuronal nicotinic ACh receptor subunit genes in cultured neonatal rat by sympathetic neurons: Specific induction of 5 by a Ca2+/calmodulin-dependent kinase pathway. J Neurosci 15, 7966–7978.
, 百拇医药
DeLean A, Munson PJ & Rodbard D (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235, E97–E102.
Devay P & McGehee DS, Yu, CR & Role LW (1999). Target-specific control of nicotinic receptor expression at developing interneuronal synapses in chick. Nat Neurosci 2, 528–534.
Fucile S, Barabino B, Palma E, Grassi F, Limatola C, Mileo AM, Alema S & Ballivet M (1997). 5 Subunits forms functional 345 nAChRs in transfected human cells. Neuroreport 8, 2433–2436.
, 百拇医药
Gerzanich V, Wang F, Kuryatov A & Lindstrom J (1998). 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal 3 nicotinic receptors. J Pharmacol Exp Ther 286, 311–320.
Girod R, Jareb M, Moss J & Role LW (2003). Mapping of presynaptic nicotinic acetylcholine receptors using fluorescence imaging of neurite calcium. J Neurosci Methods 122, 109–122.
Groot-Kormelink PJ, Boorman JP & Silvilotti LG (2001). Formation of functional 345 human neuronal nicotinic receptors in Xenopus oocytes: a reporter mutation approach. Br J Pharmacol. 134, 789–796.
, http://www.100md.com
Groot-Kormelink PJ, Luyten WHML, Colquhoun D & Sivilotti LG (1998). A reporter mutation approach shows incorporation of the "orphan" subunit 3 into a functional nicotinic receptor. J Biol Chem 273, 15317–15320.
Grynkiewicz G, Poenie M & Tsien RY (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440–3450.
Krauss KR, Carpenter DO & Kopin IJ (1970). Acetylcholine-induced release of norepinephrine in the presence of tetrodotoxin. J Pharmacol Exp Ther 173, 416–421.
, http://www.100md.com
Kristufek D, Rudorfer W, Pifl C & Huck S (2002). Organic cation transporter (OCT) mRNA and function in the rat superior cervical ganglion. J Physiol 543, 117–134.
Kedmi M, Beaudet AL & Orr-Urtreger A (2004). Mice lacking neuronal acetylcholine receptor 4-subunit and mice lacking both 5- and 4-subunits are highly resistant to nicotine-induced seizures. Physiol Genomics 17, 221–229.
Kristufek D, Stocker E, Boehm S & Huck S (1999). Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles. J Physiol 516, 739–756.
, http://www.100md.com
Lewis TM, Harkness PC, Silvilotti LG, Colquhoun D & Millar NS (1997). The ion channel properties of rat recombinant neuronal nicotinic receptor are dependent on the host cell type. J Physiol 505, 299–306.
McGehee DS & Role LW (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57, 521–546.
McNerney ME, Pardi D, Pugh PC, Nai Q & Margiotta JF (2000). Expression and channel properties of -bungarotoxin-sensitive acetylcholine receptors on chick ciliary and choroid neurons. J Neurophysiol 84, 1314–1329.
, 百拇医药
Mandelzys A, De Koninck P & Cooper E (1995). Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic receptor subunits. J Neurophysiol 74, 1212–1221.
Nai Q, McIntosh JM & Margiotta JF (2003). Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function. Mol Pharmacol 63, 311–324.
Nelson ME & Lindstrom J (1999). Single channel properties of human 3 AChRs: impact of 2, 4 and 5 subunits. J Physiol 516, 657–678.
, 百拇医药
Nelson ME Wang F, Kuryatov A, Choi CH, Gerzanich V & Lindstrom J (2001). Functional properties of nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of 34 AChRs expressed in permanently transfected HEK cells. J Gen Physiol 118, 563–582.
Rae J, Cooper K, Gates P & Watsky M (1991). Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37, 15–26.
Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A & Role LW (1996). Functional contributions of 5 subunit to neuronal acetylcholine receptor channels. Nature 380, 347–351.
, http://www.100md.com
Regehr WG & Stevens CF (2001). Physiology of synaptic transmission and short-term plasticity. In Synapses, ed. Cowan WM, Südhof TC & Stevens CF, pp. 135–175. The Johns Hopkins University Press, Baltimore & London.
Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R & De Biasi M (2003). The nicotinic acetylcholine receptor subunit 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 63, 1059–1066.
, http://www.100md.com Sharma G & Vijayaraghavan S (2003). Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron 38, 929–939.
Shoop RD, Chang KT, Ellisman MH & Berg DK (2001). Synaptically driven calcium transients via nicotinic receptors on somatic spines. J Neurosci 21, 771–781.
Silvilotti LG, McNeil DK, Lewis TM, Nassar MA, Schoepfer R & Colquhoun D (1997). Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J Physiol 500, 123–138.
, http://www.100md.com
Skok VI (2002). Nicotinic acetylcholine receptors in autonomic ganglia. Auton Neurosci 97, 1–11.
Vincler MA & Eisenach JC (2003). Immunocytochemical localization of the 3, 4, 5, 7, 2, 3 and 4 nicotinic acetylcholine receptor subunits in the locus coeruleus of the rat. Brain Res 974, 25–36.
Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K & Lindstrom J (1996). Assembly of human neuronal nicotinic receptor 5 Subunits with 3, 2, and 4 subunits. J Biol Chem 271, 17656–17665.
, 百拇医药
Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R & Korczyn AD (2004). Nicotinic acetylcholine receptor 5 subunits modulate oxotremorine-induced salivation and tremor. J Neurol Sci 222, 87–91.
Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R, Nachmann R & Korczyn AD (2002a). Autonomic function in mice lacking 5 neuronal nicotinic acetylcholine receptor subunit. J Physiol 542, 347–354.
Wang N, Orr-Urtreger A & Korczyn AD (2002b). The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice. Prog Neurobiol 68, 341–360.
, 百拇医药
Williams BM, Temburni MK, Levey MS, Bertrand S, Bertrand D & Jacob MH (1998). The long internal loop of the 3 subunit targets nAChRs to subdomains within individual synapses on neurons in vivo. Nat Neurosci 1, 557–562.
Yu CR & Role LW (1998a). Functional contribution of the 7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones. J Physiol 509, 651–665.
Yu CR & Role LW (1998b). Functional contribution of the 5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurones. J Physiol 509, 667–681.
Zhou Y, Deneris E & Zigmond RE (1998). Differential regulation of levels of nicotinic receptor subunit transcripts in adult sympathetic neurons after axotomy. J Neurobiol 34, 164–178., 百拇医药(Harald Fischer, Avi Orr-U)